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Levodopa is an α-amino acid which serves in the human organism as a direct 
precursor to a neurotransmitter dopamine and it is used as a treatment for the second 
most common neurodegenerative disease caused by age, the Parkinson’s disease. 
However, the inevitable need for gradual increase of L-DOPA dosage entails a 
deterioration in the side effects of the treatment. Hence, it is desirable to find ways of 
decreasing the necessary dosage while preserving the effect of the treatment. Until 
recently, this had been done mainly by concomitant treatment with inhibitors of 
enzymatic activity which is responsible for the undesirable extensive metabolism of 
L-DOPA. Relatively recently discovered option is the use of specifically deuterated 
derivatives of L-DOPA which, thanks to their less extensive undesirable metabolism, 
provide increased dopamine output in comparison with non-deuterated L-DOPA. 
The specificity of L-DOPA deuteration plays a crucial role in the treatment 
improvement and so does the enantiomeric purity of the drug. Levodopa is a chiral 
molecule which means that it is not identical to its mirror image. Only its L-enantiomer 
is biologically active, which is the case for all amino acids taking part in biological 
processes. Different enantiomers of chiral molecules have different optical properties 
which makes them suitable objects of study using vibrational optical activity 
techniques (including vibrational circular dichroism and Raman optical activity). 
Moreover, general vibrational spectroscopy (VS) techniques also provide a good 
characterisation of differently deuterated forms of a molecule. The main objective of 
this theses is vibrational analysis of L-DOPA and three of its differently deuterated 
derivatives. Two of them have shown an increased potency in dopamine production, 
thus, they have the potency to replace L-DOPA and become a new gold standard for 
the Parkinson’s treatment.  
The thesis is divided into 7 chapters. The first one describes the metabolism and 
the role of L-DOPA in the treatment of Parkinson’s. The second and third chapters 
give the bases of the theory and methods of VS, respectively. The fourth chapter 
outlines the basics of quantum mechanical simulations. In the fifth chapter the 
description of experimental techniques is given.  The sixth chapter presents the results 
of the experiments and simulations along with their discussion and finally, the last 
chapter sums up the results, evaluates meeting the objectives and shows a perspective 
for further research.  
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Aims of the thesis 
 
Main goal of this thesis is to perform an overall characterization of L-DOPA 
molecule by different vibrational and chiroptical spectroscopy methods and to specify 
the experimental method suitable for differentiation of differently deuterated L-DOPA 
analogues. The individual aims of this thesis can be summarized in as follows:  
1. Elaboration of a review of current employment of L-DOPA in Parkinson’s 
disease treatment.  
2. Familiarization with different methods of vibrational and chiroptical 
spectroscopy and mastering measurements on Raman spectrometer and 
micro-spectrometer, and VCD spectrometer. 
3. Obtaining IR, Raman, and VCD spectra of solid L-DOPA and its 
deuterated analogues 
4. Finding suitable measurement conditions enabling liquid phase 
measurement of Raman and ROA spectra of L-DOPA, characterization of 
differences between L-DOPA samples at different pH 
5. Obtaining high quality Raman, ROA, IR, and VCD spectra of L-DOPA 
and its deuterated derivatives and addressing spectral changes connected 
with each specific deuteration 
6. Performing simulations of vibrational spectra of L-DOPA and its 
deuterated derivatives with respect to the dynamical aspects of their 
geometry in solution, evaluation of the contribution of the different 
conformers to final simulated spectra 
7. Carrying out a vibrational analysis of experimental spectral features based 
on simulated spectral profiles, identification of characteristic spectral 
features linked with the different deuterations  
8. Comparison of experimental and simulated spectra and evaluating whether 
it is possible to distinguish between different epimers of α,β-D2-L-DOPA 








L-DOPA, also known as levodopa or L-3,4-dihydroxyphenylalanine is a small 
amino acid which occurs naturally in various animal and plant species including 
humans. In human body it serves as a precursor to a class of neurotransmitters called 
catecholamines: dopamine, noradrenaline, and adrenaline. More precisely, it is a direct 
precursor to dopamine from which noradrenaline and adrenaline, respectively, are 
derived. Neurons which synthetize dopamine are affected in patients with Parkinson’s 
disease (PD) leading to a dopamine deficiency which is responsible for the symptoms 
of the disease. Blood-brain barrier (BBB) (a selective semipermeable border between 
blood vessels and extracellular fluid of the central nervous system that prevents non-
selective crossing of solutes in blood into the brain) is impervious for dopamine 
molecule but it is permeable for a direct precursor of dopamine — levodopa. Thus, 
levodopa is used to increase dopamine levels in the brain as a treatment of PD. 
Dopamine is synthesized either indirectly form phenylalanine or directly from 
tyrosine, both of which are received from the food. The mechanism of synthesis is 
shown in the Figure 1.1. L-Phenylalanine is converted into L-tyrosine by the enzyme 
phenylalanine hydroxylase, further L-tyrosine is converted by the enzyme tyrosine 
hydroxylase into L-DOPA, and finally L-DOPA is converted into dopamine by DOPA 




Figure 1.1: Mechanism of the dopamine synthesis. (PAH, phenylalanine hydroxylase; TH, 
tyrosine hydroxylase; DDC, DOPA decarboxylase) 
 
1.1 Parkinson’s disease 
Parkinson’s disease (PD) is the second most common progressively disabling 
neurodegenerative disorder that affects 2-3% of the population over 65 years of age 
(Poewe et al., 2017). It manifests by movement disorders: bradykinesia, tremor, 
rigidity, flexed posture, postural instability, and freezing of gait; but also by non-motor 
symptoms as mood changes, anxiety, cognitive changes and sensory problems. It was 
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described by James Parkinson in the 19th century. (Marsden et al.,1976; Fahn et al., 
2004). The time progression of the clinical symptoms of PD is shown in the Figure 
1.2. 
 
Figure 1.2:  Clinical symptoms and time course of Parkinson’s disease progression. 
Addopted from (Kalia and Lang, 2015). 
 
The cause of PD is unknown, but it seems to result from a combination of genetic 
and environmental factors affecting numerous fundamental cellular processes. (Kalia 
and Lang, 2015) It causes a degeneration of dopaminergic neurons in one of the basal 
ganglia in midbrain called substantia nigra. These neurons normally produce dopamine 
and transfer it to another basal ganglion, striatum. The dopamine deficiency in striatal 
neurons leads to the motor and non-motor symptoms. Treatment of PD is thus mainly 
based on substituting dopamine loss. This is achieved for more than 50 years with 
levodopa, which is up to these days widely recognized as the most effective PD 
therapy. (Hornykiewicz, 2010; LeWitt and Fahn, 2016) 
Nevertheless, treatment with levodopa is accompanied by numerous side effects, 
including nausea, vomiting, and levodopa-induced dyskinesia (LID) which 
particularly deteriorates as the treatment proceeds. After several years of levodopa 
treatment patients start to develop motor response fluctuations called the “wearing off” 
phenomenon. That means that the symptoms of PD worsen before the next dose of 
medication is due. The condition when the medication is working and no or little 
symptoms are perceptible is referred to as an “on-state” and the state when the 
symptoms are returning is called “off-state”. Many patients experience on and off 
fluctuations several times a day. While wearing off symptoms are associated with the 
lowest plasma levels of L-DOPA and disappear when the next dose is administered, 
LID occurs at the peak plasma level of L-DOPA and alleviates with the dose reduction. 
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(Rajput et al., 2004) The biological cause of both is unknown; however, research 
suggests that wearing off and dyskinesia are caused by different pathophysiological 
mechanisms. (Rascol et al., 2000; Rajput et al., 2002, 2004; Watanabe et al. 2003) 
None of these side effects were observed in patients who were erroneously diagnosed 
with PD and received levodopa treatment for many years. (Rajput  et al., 2015) 
Current strategies of minimalizing the side effects of PD treatment are: (i) 
prolonging the peripheral plasma half-life of the drug, (ii) increasing bioavailability of 
synthesised dopamine, and (iii) achieving more continuous dopaminergic simulation. 
First two are provided by concomitant treatment with inhibitors of undesirable 
metabolic pathways of levodopa and nigral dopamine and the third one by adjusting 
the frequency and dose of the administration of drugs.  
Diagnosis of Parkinson’s disease occurs with the onset of motor symptoms (time 
0 years, see Figure 1.2) but can be preceded by a premotor or prodromal phase of 20 
years or more. This prodromal phase is characterised by specific non-motor symptoms. 
Additional non-motor features develop following diagnosis and with disease 
progression, causing clinically significant disability. Axial motor symptoms, such as 
postural instability with frequent falls and freezing of gait, tend to occur in advanced 
disease. 
Long-term complications of dopaminergic therapy, including fluctuations, 
dyskinesia, and psychosis, also contribute to the disabilities. The most common of 
them are the excessive daytime sleepiness, the mild cognitive impairment, and the 
REM sleep behaviour disorder. (Kalia and Lang, 2015) 
1.2 Pharmacokinetics of levodopa  
L-DOPA is administered to the patient orally and it has to travel a complicated 
path to its site of action in the brain. Due to an extensive first-pass metabolism about 
30-50% of L-DOPA reaches the bloodstream circulation and only 1% of the dose 
actually enters the brain. The plasma half-life of the drug is about 1 hour. (Andersson 
et al. 1975; Hauser, 2009; Waller and Sampson, 2003) Metabolism of levodopa is 





Figure 1.3: Metabolism of L-DOPA. Abbreviations include:3-OMD, 3-O-methyldopa; 
ALDH, aldehyde dehydrogenase; COMT, catechol O-methyltransferase; DA, dopamine; 
DDC, DOPA decarboxylase; DOPAL,3,4-dihydroxyphenylacetaldehyde; DOPAC, 
3,4-dihydroxyphenylacetic acid; HMPPA, 4-hydroxy-3-methoxyphenylpyruvic acid; 
HMPAL, 4-hydroxy-3-methoxyphenyl acetaldehyde; HVA, homovanillic acid; L-DOPA, 
L-3,4-dihydroxyphenylalanine; MAO, monoamine oxidase; TAT, tyrosine aminotransferase. 
Adopted from (Schneider et al. 2018) and edited. 
 
Decarboxylation by ubiquitous DOPA decarboxylase (DDC) in gut, liver, and 
kidney outbalances the other pathways; 69% of L-DOPA urinary recovered 
metabolites appear as dopamine and its metabolites. (Nutt and Fellman, 1984) 
Administration of DDC inhibitor carbidopa prolongs half-life of levodopa almost 
2-fold. Carbidopa does not cross the BBB; hence, it does not inhibit dopamine 
synthesis in the dopaminergic neurons of substantia nigra. (Deleu et al., 2002).  
Second most probable pathway is methoxylation by catechol-O-methyltransferase 
(COMT). However, if carbidopa co-treatment is introduced, it becomes the primary 
pathway, producing metabolite 3-O-methyldopa (3-OMD) which is a competitive 
inhibitor of active transport of levodopa across the BBB. (Männistö and Kaakkola, 
1989) It also competes with levodopa in the synthesis, transport and uptake of 
dopamine in the brain. (Lee et al., 2007) Administration of COMT inhibitors 
entacapone or tolcapone simultaneously with levodopa/carbidopa treatment decreases 
average levodopa daily dose, alleviates the wearing-off symptoms and increases the 
duration of the on-state. (Baas et al., 1997) BBB is permeable for tolcapone which 
allows it to act as COMT inhibitor also in the brain, leading to a higher efficiency than 
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entacapone. On the other hand, treatment with tolcapone carries the risk of hepatic 
injury and requires careful monitoring. (Factor et al., 2001; Deleu et al. 2002) 
Once dopamine is synthesised in the presynaptic neuron of substantia nigra, it is 
released in the synaptic cleft where it becomes target for methylation by COMT to 
3-methoxytyramine (3-MT) and transamination to 3,4-dihydroxyphenylacetaldehyd 
(DOPAL) by monoamine oxidase (MAO) followed by oxidation to 
3,4-dihydroxyphenylacetic acid (DOPAC) by aldehyde dehydrogenase. The former is 
regulated by COMT inhibitor tolcapone and the latter can be prevented by 
administration of  MAO-B inhibitor; e.g., selegiline which in addition to being 
MAO-B inhibitor reduces presynaptic dopamine reuptake in the brain. (Chrisp et al., 
1991; Gerlach et al., 1996) It postpones the time when levodopa treatment is necessary 
for newly diagnosed patients and once levodopa is introduced MAO-B inhibitor 
enhances its bioavailability which again reduces the wearing-off symptoms. (Ives et 
al., 2004) Common final metabolite of these pathways is homovanillic acid (HVA).  
The uptake of dopamine by postsynaptic striatal neurons can be potentiated by 
dopamine agonists. There are several of them being used for adjunct therapy or as an 
initial monotherapy for PD. (Fox et al., 2011; Connolly and Lang, 2014) Thanks to 
their long half-life they provide less pulsatile simulation of striatal dopamine receptors; 
thus, reduce the motor symptoms of PD.  
Figure 1.4 shows the summary of possible L-DOPA metabolic pathways and their 








Figure 1.4: Dopaminergic drug pathways in PD. Presynaptic targets include L-DOPA 
substitution combined with peripherally active inhibitors of aromatic amino acid 
decarboxylase (AADC) or catechol-O-methyltransferase (COMT). Monoamine oxidase type 
B (MAO-B) inhibitors enhance the synaptic availability of dopamine (both endogenous and 
exogenous), whereas dopamine agonists act postsynaptically. 
Dashed arrow from blood to brain designates blood–brain barrier (BBB) transport of L-DOPA. 
Dashed arrow through the dopamine transporter (DAT) denotes reuptake of dopamine from 
the synaptic cleft. 3-O-M-DOPA, 3-O-methyl-dopa; 3-MT, 3-methoxytyramine; D1R, 
dopamine D1 receptor; DOPAC, 3,4-dioxy-phenylacetic acid; TH, tyrosine hydroxylase. 
Adopted from (Poewe et al., 2017). 
 
1.3 Deuterated forms of L-DOPA in PD treatment 
As already mentioned before, levodopa is used as the gold standard in PD 
treatment. However, as the disease progresses, number of degenerated dopaminergic 
neurons increases, and levodopa dosage increase is required. That elicits side effects 
such as wearing-off symptoms and levodopa induced dyskinesia (LID). Thanks to a 
concomitant treatment with inhibitors of L-DOPA metabolism and dopamine agonists, 
which increase the bioavailability of L-DOPA and dopamine, respectively, lower 
doses of levodopa are necessary. Thanks to that the emergence of the side effects is 
postponed and their symptoms are attenuated. However, these co-treatments have their 
own side effects and complications. Thus, developing other ways of enhancing the 
efficiency of L-DOPA is desirable.  
Studies mentioned below have proved that triple-deuterated α,β,β-D3-L-DOPA 
(once at the α and twice at the β-carbon, Figure 1.5) exhibits higher potency in 
dopamine synthesis and a longer dopamine half-life. As a result, lower doses of 
D3-L-DOPA compared to non-deuterated L-DOPA are sufficient to achieve the same 
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efficiency. Thus, α,β,β-D3-L-DOPA may be the first drug to appear superior to 
L-DOPA in the treatment of PD. (Alken, 2016) 
1.3.1 Stereospecificity of L-DOPA metabolism 
Stereospecificity is a property of chemical reaction which yields different 
stereoisomers from different stereoisomeric reactants.  
Kinetic isotope effect (KIE) is a change in the rate of a chemical reaction caused 
by a substitution of one of the reactant’s atoms by its isotope. Primary KIE occurs 
when the bond to the isotopically labelled atom is being broken or formed whereas 
secondary KIE occurs when the isomerization is remote from the bond that is being 
broken or formed. Naturally, secondary KIE is lower than primary KIE. Hydrogen 
atom substitution by deuterium is expected to lower the reaction rate. However, in 
some reactions deuterated species react faster than non-deuterated, exhibiting so called 
inverse KIE.  
In previous research (Yu et al., 1986, 1988) the stereospecificity of dopamine 
deamination by MOA and its kinetic deuterium isotope effect was studied in vitro. 
Firstly, it was observed that decarboxylation of α-D1-L-DOPA in H2O by DDC from 
hog kidney is stereospecific. It only produces S-enantiomer of α-D-Dopamine. To 
obtain R-[α-D]-Dopamine, non-deuterated L-DOPA has to be decarboxylated in D2O. 
(Figure 1.5) 
Secondly, they have shown that MAO-A and MAO-B (from different sources 
including rat liver, human platelet, and placenta) catalyse the stereochemical removal 
of R-hydrogen/deuterium, whereas S-hydrogen/deuterium is maintained at DOPAL. 
(Figure 1.5) This was confirmed when only small reduction in the dehydrogenation of 
S-[α-D]-Dopamine in comparison to non-deuterated dopamine occurred, thanks to the 
secondary KIE, whereas the rate of oxidation of R-[α-D]-Dopamine was much slower 
thanks to the primary KIE of substituted deuterium.  
 
Figure 1.5: Metabolism of α-D1-L-DOPA; DOPA decarboxylase (DDC) catalyses the 
decarboxylation to S- [D1]-L-DOPA, which is further oxidized by monoamine oxidase to 




1.3.2 Studies in rodent model of PD disease 
Research group led by professor Torgny Svensson and associate professor Björn 
Schilström at Karolinska Institutet in Stockholm used a rodent model of PD to study 
in vivo the effects of four differently deuterated derivatives of L-DOPA on dopamine 
production: α-D1-L-DOPA, β,β-D2-L-DOPA, α,β-D2-L-DOPA and 
α,β,β-D3-L-DOPA (Figure 1.6; Malmlöf et al., 2008). Two indicators were measured 
to determine the effect of different compounds: dopamine levels and dopamine 
metabolite DOPAC levels. Their ratio was calculated to determine the dopamine 
turnover. 
α-D1-L-DOPA did not significantly affected neither dopamine levels nor its 
turnover, indicating that dopamine synthesis was attenuated due to the KIE.  
β,β-D2-L-DOPA did not significantly affected dopamine levels, but the turnover of 
dopamine was higher when compared to L-DOPA, indicating faster dopamine 
degradation due to the inverse secondary deuterium KIE. In case of α,β-D2-L-DOPA, 
dopamine production as well as its turnover was similar to that one of non-deuterated 
L-DOPA. Finally, D3-L-DOPA demonstrated increased potency in dopamine 
production and slower dopamine turnover when compared to L-DOPA.  
Previous in vivo research of dopamine deamination (Yu et al., 1986; Miller and 
Klinman 1983) and mechanism of dopa decarboxylation (Giardina et al., 2011; 
Bertoldi 2014) does not explain the strong KIE in α-D1-L-DOPA decarboxylation, the 
inverse KIE in β,β-D2-L-DOPA, or the role of simultaneous deuteration of α and 
β-carbon of L-DOPA. Also, it is not clear why the triple deuteration yields the most 
powerful effect on dopamine production and its slow degradation; however, thanks to 
this, it is the only deuterated derivative  which has higher potency in PD treatment that 
non-deuterated L-DOPA. It should be noted though, that in case of α,β-D2-L-DOPA 
there are two forms (diastereomers) differing in chirality at β carbon, which may differ 
in dopamine output and degradation; this, however, was not taken into account in these 
studies. 
 




Further research has shown that 100% of D3-L-DOPA dose is equipotent to 
approximately 60% of L-DOPA dose. Consequently, D3-L-DOPA induced less 
dyskinesias in rodents. (Malmlöf et al., 2010) 
Moreover, the effects of D3-L-DOPA alone have been proven to be similar to 
those produced by the treatment with L-DOPA combined with MAO inhibitor selegilin 
and it has been shown that pre-treatment with selegilin did not further potentiate the 
effect of D3-L-DOPA. This indicates that increased dopamine output may be attributed 
to decreased postsynaptic metabolism at MAO-B-containing sites. (Malmlöf, 2015)   
1.3.3 Studies in healthy subjects 
In a 2018 study of L-DOPA pharmacokinetics, metabolism and safety was 
performed in 16 healthy subjects after administration of single dose of the drug. It has 
shown that selective deuteration in D3-L-DOPA attenuates the peripheral metabolic 
degradation of deuterated dopamine and that peripheral pharmacokinetics and safety 
is comparable in healthy subjects to that of L-DOPA after single oral dose of the drugs.  
This study gives the first clinical evidence in human showing that selective 
deuteration in the α and β positions of the L-DOPA side chain causes a reduction of 
the metabolic breakdown of dopamine by MAO due to the intended deuterium isotope 
effect on this reaction. (Schneider et al., 2018) 
1.4 Solubility 
Solubility of a crystalline solid is dependent on its lattice energy which is a 
measure of the energy released when ions are combined to make up the crystal.  
The molecule of levodopa consists of an aromatic ring with two hydroxyl groups 
and α-amino acid chain. Amino acids are in general water-soluble thanks to their 
zwitterionic form in neutral pH, when the hydrogen from the acid carboxylic group 
transfers to the basic amine group forming a so called inner salt with the net charge 
being 0. (Figure 1.7) 
 
Figure 1.7: General α-amino acid (left) and its zwitterionic form (right). Hydrogen transfers 




 However, various R substituents interact differently with the zwitterions of 
surrounding molecules potentially affecting the lattice energy of the crystal and, 
therefore, the solubility. A solubility comparison of several amino acids in water is 
given in the Table 1.1. Solubility of phenylalanine is lowered by the presence of 
aromatic ring almost eight times when compared to alanine. Addition of a hydroxyl 
group in tyrosine further lowers the solubility fifty-six times. The second hydroxyl 
group in levodopa disrupts the lattice stability of the crystal which results in a ten times 
higher water solubility when compared to tyrosine. (Wishart et al., 2018) 
 
Table 1.1: Water solubility of different α-amino acids.  
name structure 
solubility in water 














L-DOPA in its zwitterionic form in water is soluble only up to 5 mg/ml (Wishart 
et al., 2018). It is much more soluble in basic or acidic solutes when it appears in a 
form of anion or cation, respectively. Depending on the pH, L-DOPA can have net 
charge +1, 0, -1, or -2. Theoretical dissociation constants and occurrences of different 
charge states of L-DOPA are shown in the Figure 1.8; yellow line indicates the 
zwitterionic form which outbalances the others in the pH region from 1.65 to 
approximately 8. In a strong acid L-DOPA exists in its cationic form with an extra 
hydrogen atom on the carboxylic group (red line). In basic medium, levodopa first 
loses hydrogen from the hydroxyl groups and then, with increasing alkalinity of the 
solvent, also the hydrogen from the amine group. Calculations were performed by 





Figure 1.8: Calculated dissociation constants and occurrences of different charge states of 
L-DOPA depending on the pH of the solvent. The figure is adopted and edited from 






1.5 L-DOPA as a model system  
 
The zwitterionic form of L-DOPA in solid state was confirmed by X-ray 
diffraction (Mostad et al., 1970). Further it was confirmed that L-DOPA occurs in the 
S-enantiomeric form. This is with agreement with absolute configuration 
determination of others L-amino acids.  (Mostad et al., 1971).  
L-DOPA molecule may also serve as a suitable system for testing the boundaries 
of solution state molecular simulation methods. There are four functional groups 
strongly interacting with surrounding solvent molecules in L-DOPA – two hydroxyls, 
amine, and carboxyl. Depending on the pH, they might be differently charged. Taking 
account for correct solvent-solute interactions generally means including several 
explicit solvent molecules (at least the directly hydrogen bounded molecules in the 
first solvation sphere) which substantially increases the computational cost of ab-initio 
or DFT simulation. However, the information about the dynamics and flexibility of 
those functional groups can be obtained also from the molecular dynamics. This gives 
us the possibility to test the limits of implicit solvent models used in QM simulations.  
Two vibrational spectral analysis of L-DOPA using the DFT method (Edwin and 
Hubert, 2013; Siddiqui, et al., 2010) and one study concerning the geometry 
optimisation (Elroby et al., 2012) have been published up to this point. The geometry 
optimisation study focuses rather on the bond lengths between the atoms than 
molecule’s spatial arrangement and conformational preferences. Moreover, the study 
does not take into account the zwitterionic form of L-DOPA, in which it naturally 
occurs, and does not confirm its result with an experiment. Geometry optimisation of 
neutral (non-charged) as well as differently deprotonated conformers is performed on 
the DFT/B3LYP/6-311+G** level of theory. It revealed that “the geometry of the 
phenyl ring and its OH groups is planar but alaninyl side chain acts as a free rotor 
across several single bonds” and that “the deprotonation of the carboxyl group is more 
favourable than at other sites and leads to the accumulation of excess charge density 
on the nitrogen” (Elroby et al., 2012) which corresponds to the formation of the 
zwitterion.  The 2013 vibrational study (Edwin and Hubert, 2013) works with a 
monomer and dimer of L-DOPA in the optimized geometry with the lowest energy 
from (Elroby et al., 2012). Hence, it also does not take in account the zwitterionic form 
of L-DOPA. The spectra were computed also on the B3LYP/6-311+G** level of 
theory. The study presents a comparison with experimental IR and Raman spectra, 
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however it is not very conclusive. The first conformational and vibrational study of L-
DOPA published in 2010 (Siddiqui, et al., 2010) also does not work with the 
zwitterionic form of L-DOPA. They generated the possible L-DOPA conformers by 
Monte Carlo Multiple Minimum method and chosen the one with the lowest energy. 
The IR and Raman vibrational frequencies were computed using the B3LYP functional 
and 6-311+G(d,p) basis set and were compared to experimental vibrational frequencies 
measured by Sigma-Aldrich chemical company (USA). However, none of these 
studies presents an elaborate conformational study and most importantly, none of them 
performs the geometry and frequency analysis with the zwitterionic or cationic form 
of L-DOPA molecule.   
In contrast with above mentioned publications, in this thesis we consider the 
zwitterionic and cationic form of L-DOPA both in the solid and liquid state. For DFT 
computations we use the 6-31+G**, 6-31++G**, and 6-311++G** basis sets and 
either the B3LYP or the B3PW91 functional. We compare the computed vibrational 
frequencies to four experimental spectroscopic techniques (Raman, IR, ROA, and 
VCD). The fact that we are dealing with several deuterated analogues of L-DOPA 
enables also empirical assignment of some molecular vibrations related to the C-H 
(resp. C-D) motion, which nicely accompanies the spectral interpretation based on QM 
simulations. The numbering convention of the carbons in L-DOPA molecule adopted 
in this thesis is presented in the Figure 1.9. We have chosen not to number the other 
atoms because their designation would be redundant. 
 





2 Fundamentals of vibrational spectroscopy 
Molecules in general show three types of motion – translational, rotational, and 
vibrational. Given a molecule consisting of N atoms, it has 3N degrees of freedom in 
total, including 3 translational and 3 (2 in case of a linear molecule) rotational. That 
leaves 3N-6(5) degrees of freedom for vibrations. 
For the purpose of this thesis we focus on quantum mechanical description of the 
molecular vibrations. First we deal with the approximation of Schrödinger equation 
and then with its application to the vibrational motion of diatomic molecule. In the end 
we present derivation of equations describing the vibrations of polyatomic molecules 
as well. 
We follow selected parts of Molecular Quantum Mechanics by P. W. Atkins and 
R. S. Friedman (Atkins and Friedman, 2011) and Quantum Theory of Molecules by L. 
Skála (Skála, 1995).  
2.1 Born-Oppenheimer approximation 
 
Schrödinger equation cannot be solved analytically even for the simplest molecule 
H2
+. To deal with that several approximations are used. Born-Oppenheimer 
approximation takes into consideration the great mass difference of electrons and 
nuclei. Electrons, being much lighter than the nuclei, are following their movement 
almost immediately, therefore we can account the nuclei as fixed in space and solve 
the Schrödinger equation for the electrons in their static electric potential. Also we can 
assume that nuclei react only very slowly to the change of electric field caused by the 
moving electrons so we can imagine nuclei being affected by the effective electric field 
of all the electrons.    
Further we derive the Born-Oppenheimer approximation of a non-relativistic 
Schrödinger equation for a molecule with i electrons and j nuclei: 
here ℏ is reduced Planck constant, 𝑚𝑒  is the mass of an electron, Δ is the Laplace 











+ 𝑉)𝜓 = 𝐸𝜓  (2.1) 
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electron-electron, electron-nuclei, and nucleus-nucleus interactions,  𝜓 is the wave 
function of the molecule and 𝐸 is its energy in atomic units.  
Based on the assumptions mentioned above, we can separate the wave function 
into a product of an electron wave functions in the field of j-th nucleus 𝜑𝑅𝑗(𝑟𝑖⃗ ) and the 
wave function of the nuclei 𝜒(𝑅𝑗⃗⃗  ⃗):  
𝜓(𝑟𝑖⃗ , 𝑅𝑗⃗⃗  ⃗) = 𝜑𝑅𝑗(𝑟𝑖⃗ )𝜒(𝑅𝑗
⃗⃗  ⃗).            (2.2) 
Assuming that 𝜑𝑅𝑗(𝑟𝑖⃗ ) is the solution to the Schrödinger equation of the electrons 
in the potential of a steady nuclei, then the following applies:  
 
where 𝑈(𝑅𝑗⃗⃗  ⃗)  is the effective potential energy for nuclei and it also includes the 
potential energies of internuclear repulsions at selected positions of nuclei and the 
energy of the electrons. It is called the potential energy surface of the molecule.  
By combining equation (2.2) with (2.1) and using (2.3) we get the Schrödinger 
equation of the nuclei wave functions in a so-called adiabatic approximation: 
𝑈(𝑅𝑗⃗⃗  ⃗)𝜑𝑅𝑗(𝑟𝑖⃗ )𝜒(𝑅𝑗
⃗⃗  ⃗) − ∑
ℏ2
2𝑀𝑗
𝑗 [𝜒(𝑅𝑗⃗⃗  ⃗)Δ𝑗𝜑𝑅𝑗(𝑟𝑖⃗ ) + 2 (∇𝑗𝜑𝑅𝑗(𝑟𝑖⃗ )) (∇𝑗𝜒(𝑅𝑗
⃗⃗  ⃗)) +
𝜑𝑅𝑗(𝑟𝑖⃗ )Δ𝑗𝜒(𝑅𝑗
⃗⃗  ⃗)] = 𝐸𝜑𝑅𝑗(𝑟𝑖⃗ )𝜒(𝑅𝑗
⃗⃗  ⃗).      (2.4) 
Furthermore, assuming that the wave function of electrons 𝜑𝑅𝑗(𝑟𝑖⃗ ) changes only little 
with the movement of the nuclei which is called Born-Oppenheimer approximation, 
we get 
Δ𝑗𝜑𝑅𝑗(𝑟𝑖⃗ ) = 0,      






Δ𝑗𝜒(𝑅𝑗⃗⃗  ⃗) + 𝑈(𝑅𝑗⃗⃗  ⃗)𝜒(𝑅𝑗⃗⃗  ⃗) = 𝐸 𝜒(𝑅𝑗⃗⃗  ⃗), (2.6) 
where 𝐸 is the total energy of the molecule, consisting of the translational, rotational, 
vibrational and electronic energies:  








+ 𝑉)𝜑𝑅𝑗(𝑟𝑖⃗ ) = 𝑈(𝑅𝑗




2.2 Vibrations of diatomic molecules 
2.2.1. Harmonic approximation 
When nuclei are displaced from the equilibrium position, theirs potential energy 
𝑉(𝑥) increases. For small displacement 𝑥 we can expand the potential into Taylor 
series and neglect terms higher than second order. Furthermore, we can set the 










.          (2.8) 

















 is the effective mass.  
Equation (2.9) corresponds to a Hamiltonian of a linear harmonic oscillator for which 
the solution is well known:  
𝐸 = ℏ𝜔 (𝜐 +
1
2
) , where the frequency 𝜔 = √(
𝑘
𝑚
)  .  (2.10) 
Here 𝜐 = 1,2,…  are individual vibrational energy levels of the molecule equally 
separated by the distance ℏ𝜔. 
2.2.2. Vibrational selection rules 
Consider a molecule in the state |𝜀, 𝜈⟩  where 𝜀 and 𝜈 denote its electronic and 
vibrational state, respectively.  The change of the electric dipole moment operator 
?̂? under the transition from one vibrational state (𝜈) to another (𝜈′) is given by the 
transition matrix element  
?̂?𝜈′𝜈 = ⟨𝜈′|?̂?𝜀  |𝜈⟩.         (2.11) 
Here ?̂?𝜀 is dipole moment of the molecule in a particular electronic state 𝜀. We get that 
by performing the integration over the electronic state which can be done separately 
thanks to Born-Oppenheimer approximation.  
The dipole moment depends on the displacement of nuclei, therefore we can 
expand it into Taylor expansion as  

















where ?̂?0 is the dipole moment for null displacement.  
By combining equations (2.11) and (2.12), taking into account the orthogonality 
of the vibrational states for 𝜈′ ≠ 𝜈  and considering only small displacements (i.e. 
neglecting the terms of higher order than linear), we get the transition matrix element 






which is non-zero only when the dipole moment varies with displacement.  
Hence we can conclude that for a molecule to show vibrational spectra, it must 
have a dipole moment which changes with displacement of the nuclei.  
By further investigation of the conditions under which ⟨𝜈′|𝑥|𝜈⟩ ≠ 0 it was found that 
the allowed vibrational transitions are only those when initial and final vibrational 
states differ by unity, i. e. 
 Δ𝜈 = ±1.     (2.14) 
This is the selection rule for vibrational transition of an electric dipole in harmonic 
approximation, it only allows transitions between two neighbouring vibrational levels.  
2.2.3. Selection Rules for Raman transition 
For Raman transition the induced dipole moment is defined by the polarizability 
?̂?: 
?̂? = ?̂??̂?.                (2.15) 
Using the same approach as in section 2.2.2., we can separate electronic and 
vibrational wavefunction, evaluate ⟨𝜀|?̂?|𝜀⟩, and write:  





∙ ?̂?⟨𝜈′|𝑥|𝜈⟩, (2.16) 
which again leads us to the conclusion that for the vibration to be visible in the Raman 
spectrum, the displacement of the atoms must change the polarizability of the 
molecule. Also the Raman selection rules are the same as the vibrational ones:  





2.2.4. Polyatomic molecules  
 
In practise we always deal with the vibrations of atoms in polyatomic molecules, 
in which the potential energy depends on the displacements of all atoms in the 










We now introduce the mass-weighted coordinates 𝑞𝑖 = √𝑚𝑖𝑥𝑖 , where 𝑚𝑖 is the 






𝑞𝑖𝑞𝑗   , where 𝐾𝑖𝑗 = (
𝜕2𝑉
𝜕𝑞𝑖𝜕𝑞𝑗
) . (2.19) 












𝑞𝑖𝑞𝑗 . (2.20) 
The terms which make difficulties in the computation are those where 𝑖 ≠ 𝑗; 
therefore, it is desirable to find a linear combination 𝑄𝑖 of the coordinates 𝑞𝑖 thanks to 













2,  (2.21) 
with 𝜆𝑖being the coefficients.  
Some of the linear combinations 𝑄𝑖 correspond to the translational and rotational 
motion. For such we expect 𝜆𝑖 = 0. Linear combinations that enable this separation 
are called normal coordinates.  
 










2 . (2.22) 
For a non-linear molecule the Hamiltonian is a sum of 3N-6 harmonic-oscillator 
Hamiltonians, each corresponding to one of the independent vibrating modes 𝜐𝑖 of the 
molecule which are called the normal modes. The wavefunction of the molecule 𝜓 is 
the product of all the 3N-6 wavefunctions of the normal modes:  
𝜓 = ∏ 𝜓𝜈𝑖(𝑄𝑖)
3𝑁−6
𝑖=1
.   (2.23) 
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Total energy of the molecule is the sum of the energies of normal modes: 






 ℏ𝜔𝑖 ,  
(2.24) 
where 𝜔𝑖  is the frequency of the mode.  
Regarding the selection rules for vibrational and Raman transition, we can extend 
them to the normal coordinates by rewriting the equations (2.13) and (2.16) for each 
normal vibrational mode 𝜈𝑖  as 










∙ ?̂?⟨𝜈𝑖′|𝑄𝑖|𝜈𝑖⟩,  (2.25) 
respectively. 
Allowed transitions are in both cases those where 𝜈𝑖
′ = 𝜈𝑖 ± 1. The fundamental 
transition of a molecule is such during which a single mode transits from 𝜈𝑖 = 0 to 
𝜈𝑖′=1 and vice versa while all the others remain in the same level. 
If the displacement of a nuclei along normal coordinate changes the electric dipole 





≠ 0, then the appropriate normal mode 𝜈𝑖 is said to be infrared 
active because it contributes to the vibrational IR absorption or emission of the 
molecule. If, on the other hand, the displacement of nuclei along normal coordinate 





≠ 0, the appropriate normal mode 𝜈𝑖 is said 





3 Methods of vibrational spectroscopy 
By applying electromagnetic radiation of different energies, we are able to study 
different transitions in the molecule. Frequencies of molecular vibrations correspond 
mostly to the frequencies of the infrared part of electromagnetic radiation. Hence, to 
study vibrational transitions, we use infrared spectroscopy (IR) based on direct 
absorption of infrared light, or Raman spectroscopy (RS) based on the inellastic 
scattering of visible light.  
The positions of the peaks in the spectra are usually given by their wavenumber, in 




 , (3.1) 
where 𝜆 is the wavelength corresponding to the frequency of the vibration.  
Vibrational spectra of the molecules can be divided into three regions: (i) 
low-wavenumber region (0 – 400 cm-1), (ii) so called fingerprint region (around 400 – 
1400 cm-1) which is unique for each compound, and (iii) the functional group region 
(around 1400 – 4000 cm-1) where the vibrations of functional groups occur. (El-Azazy 
2018) Infrared spectrometers usually operate in the mid infrared region, that is 2.5-25 
μm (around 400 – 4000 cm-1), and the absorbed frequencies give rise to the absorption 
spectra. Raman spectrometers, on the other hand, use only monochromatic source of 
visible light which is not absorbed by the molecule. Such light is being scattered 
mostly without the change in energy by Rayleigh scattering; however, some of the 
scattered light (approximately one millionth of it) is scattered inelastically having 
higher or lower energy, giving rise to the anti-Stokes or Stokes lines in Raman spectra, 
respectively.  
In this chapter we describe the general theory of vibrational spectroscopy and also 
the theory of specific methods used in our work. We follow selected parts of (Prosser 




3.1 Infrared absorption spectroscopy (IR) 
3.1.1. Process of absorption 
When light of a frequency 𝜐  passes through translucent material its intensity 
decrease.  Physical quantity characterising this phenomena is called absorbance and it 
is defined as 
where 𝐼0(𝜐) and 𝐼(𝜐) are the intensities of incident and transmitted light, respectively. 
According to Lambert law, absorbance depends linearly on the distance 𝑙 travelled by 
light in the sample being propotional to the attenuation coefficient 𝑏: 
𝐴(𝜐) = 𝑙𝑏(𝜐).       (3.3) 
By combination of equations (3.2) and (3.3) we arrive to the expression for the 
intensity decrease  
𝐼(𝜐) = 𝐼0(𝜐)𝑒
−𝑏(𝜐)𝑙.     (3.4) 
Furthermore, according to the Beer law the extinction coefficient is proportional 
to the molar attenuation coefficient 𝜀(𝜐) and the molar concentration of the sample 𝑐: 
𝑏(𝜐) = 𝑐 𝜀(𝜐).     (3.5) 
Thus we obtain the Beer-Lambert law for absorbance: 
𝐴(𝜐) = 𝑙𝑐𝜀(𝜐)     (3.6) 
The most common technique of acquisition of absorption spectra of liquid sample 
in a cuvette is measuring the transmittance 𝑇(𝜆) which is defined as the ratio of the 











  is measured, where 𝐼𝑟𝑒𝑓(𝜆) is the intensity of light 
transmitted through the cuvette containing the pure solvent.  
3.1.2. IR spectrometers 
Modern IR spectrometers are built as Fourier transform infrared spectrometers 
(FTIR). As the name implies, they use two Fourier transforms to obtain the spectra. 
First one is performed by the interferometer which is built-in the spectrometer. We 




 , (3.2) 
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Figure 3.1. Light from the black body-like source is split by a beam splitter into two 
separate beams. One of them continues to a fixed mirror (in distance 𝑙) where it reflects 
and travels back. The second one is reflected from a movable mirror. If the mirror 
deflection from the distance 𝑙 is 𝑑, it generates a length difference 2𝑑 in the path of 
both beams. When the two beams interfere, constructive interference happens only for 
the wavelength 𝜆 for which 𝑑 =  
𝑘𝜆
2
, where 𝑘 is an integer. By detecting transmittance 
for different values of 𝑑, the interferogram is obtained and subsequently converted to 
a transmission spectrum by the second Fourier transform performed by a computer.   
 
Figure 3.1: Michelson interferometer: by changing the distance 𝑑, only the wavelengths for 
which 𝑑 =  
𝑘𝜆
2
, where 𝑘 is an integer, are selected from continuous spectra.  
 
The use of Fourier transform is conditioned by the advances in microtechnology. 
In the past only dispersion infrared spectrometers were used. These measure 
transmittance of only one wavelength at a time using a monochromator. Nowadays, 
dispersion spectrometers are not used for routine measurements because of their 
relatively high signal-to-noise ratio and long measurement time compared to FTIR 
spectrometers, but they are still used for special applications like time-resolved 





3.2 Raman spectroscopy 
 
3.2.1 Raman effect  
Let us consider a molecule in a ground electronic state. In contrast to absorption, 
where molecule changes its vibrational or electronic state and the energy of the 
absorbed photon is the same as the energy difference of the vibrational or electronic 
states, Raman scattering is an off-resonance two-photon process in which the molecule 
is excited into unstable virtual energy state. From there it immediately transits back 
into a) the ground electronic state, in which case we are dealing with elastic Rayleigh 
scattering, b) one of the higher vibrational energy states of the electronic ground state 
which leads to Stokes Raman scattering, hence the molecule gains energy, or c) the 
molecule’s initial energy state is one of the higher vibrational states and after absorbing 
the radiation it transits to the ground vibrational state by emission of a photon of higher 
energy than that of absorbed photon. The last case is called anti-Stokes Raman 
scattering and the molecule loses energy.  Figure 3.2 illustrates all three possible 
transitions. Although it is not technically process of absorption and emission, it is often 
referred to as such. 
 
Figure 3.2: Three possible transitions of molecular energy state after absorption of light: a) 
Rayleigh scattering, where the energy of emitted light is the same as of the incident light b) 
Stokes Raman scattering, where the energy of emitted light is lower than that of the incident 
light c) anti-Stokes Raman scattering where the energy of emitted light is higher than that of 




The difference in wavelengths of incident and emitted radiation ( 𝜆𝑖  and 𝜆𝑒 , 
respectively) is called the Raman shift and it corresponds to the energy difference 
between initial and final state of the molecule. It is defined as    
Therefore, the magnitudes of the shifts of Stokes and anti-Stokes lines are the same for 
given vibrational state and they are independent of the initial light frequency.  
Intensity of scattered light increases with the fourth power of the frequency of the 
incident light.  The vast majority of incident photons, more than 99,9999 %, is 
scattered elastically. The probability (cross section) of Raman scattering is much 
lower, only one of every 106-108 photons scatters inelastically. (Smith and Dent, 2004) 
Therefore, Raman lines in molecule’s spectra are much less intense. Moreover, 
because the vast majority of molecules occurs in the ground state at room temperature, 
the intensity of anti-Stokes lines is even lower than that of the Stokes lines. An 
illustration of Raman spectrum is shown in Figure 3.3.   
 
 
Figure 3.3: Illustration of Raman spectrum. In the middle at 𝜈0  (frequency of the incident 
radiation), is shown the Rayleigh line of elastic scattering, the left side of the spectrum is 
formed by anti-Stokes lines and the right side by Stokes lines. The value of frequency increases 
from right to left. Raman shift ∆𝜈𝑖 equals to energy difference between molecule’s initial and 
final state.  
 
Using the classical theory we can describe the Raman effect as follows (B&W 
Tek., 2019): Consider a polarized coherent monochromatic light oscillating with 
frequency 𝜈0 and amplitude 𝐸0. Such light can be described by equation of harmonic 
electric field  







 .  (3.8) 
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This light interacts with the electron clouds of the molecules and distorts them, creating 
a dipole moment μ of properties dependent on the ability of the electron cloud to be 
polarized: 
μ = αE .     (3.10) 
If the molecule vibrates with the frequency 𝜈𝑚 and amplitude 𝑥0, the displacement of 
the nucleus 𝑥 is given by equation 
𝑥 = 𝑥0cos (2𝜋𝜈𝑚𝑡).       (3.11) 
Polarizability is a function of  𝑥 hence for small amplitude of vibration we can use 
harmonic approximation of polarizability: 






where 𝛼0 is the equilibrium position of polarizability. 
Combining equations (3.9)-(3.12) we get  













The first term of equation (3.13) represents a dipole oscillating with frequency  𝜈0 
which corresponds to the Rayleigh scattering. The other two terms representing dipoles 
with frequencies (𝜈0 − 𝜈𝑚)  and (𝜈0 + 𝜈𝑚)  correspond to Stokes and anti-Stokes 
Raman scattering, respectively. If (
𝜕𝛼
𝜕𝑥
) = 0 , the last two terms would disappear 
meaning that the vibration is Raman-inactive.  
3.2.2  Raman spectrometer  
Unlike in IR absorption, monochromatic source of light is sufficient in Raman 
spectrometers to obtain the whole Raman spectra. Since the intensity of scattered light 
is proportional to the fourth power of its frequency, it seems desirable to work in the 
UV region but unfortunately many compounds absorb UV radiation which leads to 
complications in obtaining UV Raman spectra. Thus, most Raman spectrometers 
employ visible or near IR lasers.  
Even though Fourier-transform Raman spectrometers with near IR light source 
exist, the most common are disperse Raman spectrometers which use visible light for 
excitation. (Smith and Dent, 2004) In principle, scattered light can be collected from 
every direction, however, three main scattering geometries are employed in common 
practice – forward scattering, right-angle scattering, and backward scattering (see 
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Figure 3.4). In forward scattering the laser beam passes through the sample and the 
scattered light is collected behind the sample while the laser beam is screened out.   In 
90˚ geometry the laser beam passes through the sample and the scattered light is 
collected by a lens positioned at 90˚ with respect to the beam. In the backward, or 180˚, 
geometry the path of the laser beam is guided by a system of mirrors to the lens-sample 
connecting line. The last geometry is mostly used in Raman microscopes.  
Most of the scattered light collected by lenses is due to the Raleigh scattering. This 
is filtered out usually by a notch filter which absorbs at the frequency of incident laser 
light and a little band around it (usually within 200 cm-1) or edge filter which cuts off 
the Rayleigh as well as the anti-Stokes Raman scattering. Filtered light then passes 
through a monochromator which spatially separates different wavelengths of Raman-
scattered light and finally it is recorded by a coupled charged device (CCD) detector. 
(Smith and Dent, 2004) 
 
 
Figure 3.4: possible geometries of Raman spectrometer. a) forward-scattering geometry b) 90˚ 
geometry c) 180˚ geometry.  
 
3.3 Vibrational optical activity (VOA)  
 
Methods of VOA are based on the optical activity of chiral molecules. They 
include two separate techniques: vibrational circular dichroism (VCD) and Raman 
optical activity (ROA), both resulting in difference vibrational spectra with respect to 
right- and left-circularly polarized light. Former reveals optical activity of molecules 
using IR absorption and the latter uses Raman scattering.  
3.3.1 Chirality  
Chiral molecules are such which are not similar to their mirror images (as shown 
in the Figure 3.5). In organic molecules the most common cause of chirality is the 
presence of a carbon that is attached to four different atoms or atom groups, so called 
asymmetric carbon. The molecules which differ only in the spatial arrangement of the 
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atoms are called stereoisomers and one of such molecules is referred to as an 
enantiomer.  
 
Figure 3.5: Demonstration of left handed and right handed chiral molecule. Adapted from 
(Renstrom, 2018). 
 
There are several nomenclatures which use different conventions to distinguish 
between the enantiomers:  
(i) by absolute configuration of the molecules we distinguish R- and 
S-enantiomers (Figure 3.6). Each atom or group on the chiral centre is assigned a 
priority based on its atomic number. The centre is then oriented so that the atom with 
the lowest priority points away from the viewer. The crucial criterion is if the priority 
of the remaining substituents decreases in clockwise direction, in which case we are 
dealing with R- enantiomer (R stands for Latin word Rectus which means right), or 
anti-clockwise which is the case of S- enantiomer (S for Sinister, Latin for left). 
 
Figure 3.6: Example of S- and R- enantiomers. 
 
(ii) Enantiomers differ in their optical activity. Based on that we distinguish 
enantiomers which rotate the plane of polarized light clockwise, the (+)- enantiomer, 




Figure 3.7: Illustration of right- and left-circularly polarized light and (+) - and 
(−)-enantiomers of the same molecule. (Nafie, 1996) 
 
(iii) By compound’s stereochemistry relative to the geometry of the 
dextrorotatory, (+) -, or levorotatory, (– ) -, enantiomers of glyceraldehyde we 
distinguish D- and L-enantiomers, respectively. This convention is not related to the 
actual optical activity of the molecules, dextrorotatory enantiomer of glyceraldehyde 
is indeed an D-enantiomer, however, 9 of 19 L-amino acids commonly found in the 
proteins are dextrorotatory. 
 
3.3.2 Vibrational circular dichroism (VCD) 
IR absorption associated with VCD is a one-photon process. Hence, there is only 
one way to define VCD – as the difference of absorbance of the sample for left- and 
right-circularly polarized light:  
∆𝐴 = 𝐴𝐿 − 𝐴𝑅. (3.14) 
Illustration of the process of absorption is shown in the Figure 3.8 bellow. Letters g 
and e mark the ground and excited electronic or vibrational state of the molecule, 𝑅 
and 𝐿  the right- and left-circularly polarized ligh, respectively, and 𝐴  marks the 
absorption of light.  
 
Figure 3.8: Process of absorption of right- (R) or left- (L) circularly polarized light. Adapted 
from (Nafie, 1995). 
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Intensity of VCD signal depends on the magnetic-dipole interactions of molecule 
and radiation. The anisotropy ratio 𝑔 is defined as the ratio of experimental VCD 
















Here 𝜇  and ?⃗⃗?  denote the electric and magnetic dipole transition moment, respectively. 
Dipole strength is always positive, whereas the sign of the rotatory strength depends 
on the relative directions of the electric and magnetic dipole transitions moments. 
   
3.3.3 Raman optical activity (ROA) 
Raman scattering, on the contrary of absorption, is a two photon process; 
therefore, there are more possibilities to the arrangement of ROA experiment. Namely, 
incident circular polarization (ICP) ROA, scattered circular polarization (SCP) ROA, 
in-phase dual circular polarization (DCPI) ROA and out-of-phase dual circular 
polarization (DCPII) ROA. As their names imply, they differ in the polarization of the 
incident and detected scattered light. All forms of ROA are shown in the Figure 3.6 
and they are defined as follows:  
ICP: ∆𝐼𝑢(𝜉) = 𝐼𝑢
𝑅(𝜉) − 𝐼𝑢
𝐿(𝜉) 
SCP: ∆𝐼𝑢(𝜉) = 𝐼𝑅
𝑢(𝜉) − 𝐼𝐿
𝑢(𝜉) 
DCPI: ∆𝐼𝐼(𝜉) = 𝐼𝑅
𝑅(𝜉) − 𝐼𝐿
𝐿(𝜉) 
  DCPII: ∆𝐼𝐼𝐼(𝜉) = 𝐼𝐿
𝑅(𝜉) − 𝐼𝑅
𝐿(𝜉).   (3.17) 
The superscript and subscript denote the polarization of the incident and detected 
radiation, respectively, 𝑢 stands for unpolarised, and 𝜉 is the scattering angle which 
depends on the spectrometer geometry. For instance, in case of ICP-ROA the 
polarization of incident radiation is modulated between right and left circular states 
and unpolarised scattered light is detected. The most commonly used techniques are 





Figure 3.9: Different arrangements of ROA experiments. (Nafie, 1996) 
 
Like in the case of VCD, intensity of ROA also depends on the magnetic-dipole 
interactions of the molecule and radiation, but ROA additionally depends also on the 
electric-quadrupole interaction.  
ROA intensity is expressed as the circular intensity difference (CID). It is the ratio 
of ROA to regular Raman intensities, which can be theoretically expressed as the ratio 
of linear combinations of ROA tensor invariants to ordinary Raman polarizability 











where 𝛽(𝐺)2 and 𝛽(𝐴)2are the magnetic-dipole and electric-quadrupole anisotropic 
Raman optical activity invariants, respectively, and 𝛼 and 𝛽(𝛼)2 are the isotropic and 
anisotropic Raman polarizability invariants. 
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3.4 Comparison of IR and Raman spectroscopy  
 
Raman and IR spectroscopy are complementary techniques. They use different 
physical phenomena to gain spectra of molecules and usually the employment of both 
of them is beneficial for acquiring the detailed information about vibrational behaviour 
of studied molecule. While IR spectra are the result of one-photon resonance process, 
the absorption of electromagnetic radiation, Raman spectra are produced thanks to an 
off-resonance two-photon inelastic scattering process. Raman spectroscopy depends 
on a change of polarizability of a molecule, whereas IR spectroscopy depends on a 
change in the dipole moment. Raman spectroscopy is best at vibrations of nonpolar or 
homo-nuclear groups, while IR spectroscopy is best at the asymmetric vibrations of 
polar or hetero-nuclear groups. (Larkin, 2017; Exline, 2013). 
The advantage of Raman spectroscopy is that it requires little to no sample 
preparation, while the IR spectroscopy is limited by the requirement of sample 
uniformity, thickness, and dilution to avoid high absorbance. Moreover, the 
measurable spectral range of sample’s absorption is limited by the cuvette absorbance. 
IR spectra, on the other hand, are not affected by the fluorescence of the sample; 
however, IR absorbance of water often intervenes with the liquid sample spectra, if 
used as a solvent.  (Exline, 2013).  
Following table gives a summary of main differences between Raman and IR 
spectroscopy: 
Table 3.1: Comparison of Raman and infrared spectroscopy. Adopted from (Peeran, 2005) 
Raman IR 
It is due to the scattering of light by the vibrating 
molecules. 
It is the result of absorption of light by vibrating 
molecules. 
The vibration is Raman active if it causes a change in 
polarisability. 
Vibration is IR active if there is change in dipole 
moment. 
The molecule need not possess a permanent dipole 
moment. 
The vibration concerned should have a change in 
dipole moment due to that vibration. 
Water can be used as a solvent. Water cannot be used due to its intense 
absorption of IR. 
Sample preparation is not very elaborate, it can be in 
any state. 
Sample preparation is elaborate 
Gaseous samples can rarely be used. 
Gives an indication of covalent character in the 
molecule. 
Gives an indication of ionic character in the 
molecule. 





4 Quantum mechanical simulations 
Computational simulations of molecular properties have wide range of 
applications in physical chemistry including interpretation of experimental spectra, the 
absolute configuration determination, determination of the structure of biomolecules 
and biomolecular systems, and the elucidation of their mechanism of action. Large 
molecules with high degrees of freedom are modelled empirically with the use of 
molecular force fields models of smaller compounds. Small and medium sized 
molecules with less than 100 atoms can be computed using ab-initio methods.  
4.1 Ab-initio methods  
Ab-initio calculation methods are based merely on the laws of physics, lacking the 
use of empirical data. Their aim is to solve the multi-electron Schrödinger equation of 
a molecule in Bohr-Oppenheimer approximation (see section 2.1). However, the 
Schrödinger equation can be solved analytically only for one-electron systems such as 
hydrogen atom and diatomic hydrogen ion. Thus, for the multi-electron atoms and 
molecules, it has to be solved numerically with the employment of approximate 
methods such as the variational principle and perturbation theory. Ab-initio 
computations of properties of larger molecules or molecular systems tend to be time 
and cost consuming. 
The available quantum chemical methods can be divided into wavefunction and 
density-based methods, depending on whether they are built upon an ab initio 
wavefunction requiring a Hartree – Fock ground state calculation as prerequisite, or 
whether they formally require a ground state electron density derived from Kohn – 
Sham density functional theory (DFT). (Comba, 2011) 
4.1.1 Hartree-Fock theory (HF) 
HF, also called the Self-Consistent Field method (SCF), is an iterative technique 
which uses a model of non-correlated electrons to obtain the molecular orbitals. 
Thanks to the approximation of non-interacting electrons, the wave function of the 
stationary state can be represented by the Slater determinant, a product of 
single-electron wave functions (i.e. spin-orbitals for the calculation of an atomic 
orbital or the linear combination of atomic orbitals, LCAO, for a molecular orbital) 
and the Hamiltonian as a sum of single-electron Hamiltonians in Born-Oppenheimer 
approximation. Subsequently, the variational method is used to find the energy 
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estimate and the coefficients of the atomic orbitals in the LCAO. HF method is then 
iterated with thus created wavefunction until the energies converge. The derivation of 
HF and illustrative calculations can be found for instance in (Szabo and Ostlund, 
1996).  
The advantage of HF method is a low computational expense. Nevertheless, the 
neglect of the electron correlation can lead to large disagreement with the experimental 
data. Therefore, to improve the molecular model, it is necessary to include the 
correlations and interactions of the electrons. There are different approaches of doing 
so and all together are called the Post-Hartree-Fock methods. Their summary can be 
found in (Townsend et al., 2019 and Magnasco, 2013) 
The refinement of the computational results usually requires much higher 
computational power and it is therefore costly and even unaffordable for large systems.  
4.1.2 Density functional theory (DFT) 
A different approach of computing the electronic structure is represented by DFT. 
It introduces the concept of an electron-density distribution of the physical system 
which contains the same information as the wavefunction. The ultimate goal of DFT 
is calculation of electron-density distribution without the use of the wave function of 
the system. (Piela, 2020) Unlike HF theory, it does not neglect the correlation of the 
electrons; it rather takes them into account form the very beginning.  
DFT relies on the formulation of the Hohenberg-Kohn (HK) theorem which 
postulates the existence of exchange-correlation functional which is minimized by the 
ground-state electron density distribution giving the energy of the ground state. The 
ground-state energy includes the problematic exchange-correlation energy of the 
electrons which corresponds to the exchange-correlation potential. The mathematical 
form of the HK functional is not known, but its approximations yield results that are 
highly sufficient. Once the energy approximation is obtained, the iterative process of 
solving HK equations (analogous to the HF method) is applied until the energy 
converges.  
The most popular functional used to approximate the exchange-correlation 
functional is B3LYP. It is a hybrid of other types of functionals with their individual 
contributions balanced so that it gives the best possible result.  In this work we use 
B3LYP (Kim and Jordan, 1994) for the identification of stable conformations of 
significant dihedral angles and B3PW91, which is another hybrid functional, for 
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further computations. Overview of commonly used functionals can be found in 
(Devlin, 2019) 
DFT is not an ab-initio method per se because, in practise, a few empirical data 
are needed for the guess of the functional. So far there is no way of systematically 
improving the functional in order to yield better results. Nonetheless, the average cost 
of a DFT calculation is still extremely convenient in calculations of moderate accuracy 
for molecular systems of chemical complexity. (Magnasco, 2013) 
4.1.3 Basis sets 
Basis sets are sets of functions used in HF and HK methods to yield the 
wavefunction or electron-density distribution, respectively. In quantum-chemistry 
computations the basis functions used are usually the atomic orbitals. Atomic orbitals 
can be Gaussian-type, Slater-type or numerical. The most commonly used are 
Gaussian-type orbitals.  Basis sets used in this work are composed of Gaussian-type 
orbitals — the double and triple-zeta Pople basis sets 6-31+G* and 6-311++G**. 
4.2 Spectral simulations 
To compute spectra in a good agreement with the experiment, we need to simulate 
the molecule as realistically as possible.  Given the nature of spectroscopic methods, 
where the specimen is often dissolved in a solvent in order to perform the 
measurement, it involves taking in the consideration its interaction with the solvent. 
After the most probable conformations of the molecule in the particular solvent are 
determined, the vibrational frequencies and intensities can be computed for each 
conformation separately giving their full spectra. The final spectra is obtained by their 
Boltzmann average. 
4.2.1 Geometry optimization 
Prior to the geometry optimization, it is necessary to find all possible conformers 
of the molecule by scanning over its torsion angels and finding the position in which 
the energy of the molecule is minimal. Subsequently, conformers with all possible 
combination of the found minima of torsion angles are compiled and the geometry 
optimisation is performed on each single one of them. 
It is done so by an iterative algorithm which is designed to find the minima (which 
correspond to the stable form of the molecule) and maxima (which correspond to the 
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transition states) of the potential energy surface (PES) by changing the coordinates of 
the molecule. 
The essence of all geometry optimization algorithms is the computation of the 
Newton-Raphson step towards the local minimum or maximum on the PES. It requires 
the computation of first and second derivatives of the energy; that is, the gradient 
vector 𝑔 ⃗⃗  ⃗ and the Hessian matrix H, respectively.  The Newton-Raphson step is then 
defined as ℎ ⃗⃗⃗  = −𝐻−1 𝑔 ⃗⃗  ⃗. If all the elements of diagonalized Hessian are positive, i.e., 
the matrix is positively definite, the step taken will attempt to minimize the energy; if 
only one element is negative, the step will attempt to maximize the energy in that 
direction while minimizing it in all the others, heading toward a transition state. When 
the minimum on PES is reached, the gradient is equal to zero and the Hessian is 
positively definite.  
Even though all quantities in ab-initio methods are computed and stored in the 
Cartesian coordinates, that is in Z-matrix, those are usually not the best choice for the 
geometry optimization algorithm itself because of their high level of coupling. 
Defining the molecule in a set of internal coordinates often results in the need of less 
optimization cycles, hence, a faster convergence of the used algorithm. 
Nowadays, Cartesians are being replaced by the set of delocalized internal 
coordinates (that is linear combinations of bond lengths, valence angles and torsions; 
Baker, 1996), the generalized internal coordinates (Fogarasi, 1992), which are derived 
directly form the normal coordinates used in the theory of molecular vibration 
discussed in the section 2.3, or some other set of redundant internal coordinate system 
(Pulay and Fogarasi, 1992; Peng et al., 1996). All of them are readily derived from the 
Cartesian Z-matrix input during every optimization step. More details about geometry 
optimization algorithm can be found in (Schlegel, 2011 or Baker, 2017) 
For the spectral simulation it is necessary to identify the minima of PES 
corresponding to the major stable conformers of the molecule and subsequently to 
include all of these conformers in the computation of spectra.  
4.2.2 Vibrational frequencies and intensities  
After the conformational analysis is performed, the spectra, i.g., the vibrational 
frequencies and intensities of major stable conformers can be computed. It is important 
to perform this computation on the same level of theory as the geometry optimization. 
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Vibrational frequencies and intensities can be obtained from the mass-weighted 
Hessian matrix in Cartesian coordinates. The procedure involves following steps: 1) 
separating the translational and rotational motion by shifting the coordinate system 
into the centre of mass and projecting the Hessian into the rotational reference frame 
defined by the principal axes of inertia; 2) diagonalization of the projected matrix. 
The eigenvalues of hereby obtained matrix give the force constants of normal 
modes which are easily converted to the frequencies (eq. 2.10) and wavenumbers (eq. 
3.1). Its eigenvectors, after being mass-weighted and normalized, yield the normal 
modes.  
Computation of intensities differs for each vibrational method. For IR and VCD 
spectroscopies it involves computation of dipole and rotatory strength (eq. 3.19). In 
case of ROA and Raman spectroscopies the corresponding invariants (eq. 3.20) are 
computed. Details about VOA spectral intensity calculation can be found e.g. in 
(Nafie, 2011). 
The bandshape of experimental spectra is Lorentzian curve, hence, the final 
spectra are calculated by performing a convolution of the obtained intensities with 
Lorentzian function.  
The presence of different conformers with different spectra is dealt with by 
computing the Boltzmann average of the spectra weighted by the calculated energies 
of the conformers. 
4.2.3 Solvent models 
Incorporating the solvent in the model can be done in three ways: implicitly, 
explicitly, or by a combination of these two approaches. An overview of developed 
models along with their advantages and disadvantages can be found in (Skyner, 2015).  
Implicit approach is less computationally demanding but does not take into 
account the local fluctuations of solvent density around the molecule. The solvent is 
modelled as homogenously polarizable medium and the main parameter is the 
dielectric constant, i.e., the relative permittivity 𝜀 of this medium. The solute is placed 
in a cavity with the correspondent charge distribution on its surface. The solvent 
surrounds the cavity and is being polarized by it.  
Commonly used implicit model are the Polarizable Continuum Model (PCM) 
which is rather a family of models which treat the solute as a polarizable dielectric 
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(Tomasi, 2005), Conductor-like Screening Model (COSMO), which considers ε = ∞ 
(Klamt and Schürmann, 1993) or Solvation Model Based on Density (SBD). 
In this work a conductor-like PCM (C-PCM) version of PCM is used. It is a 
combination of COSMO and PCM where the dielectric permittivity is ε = ∞ which 
simplifies the computation.  (Barone and Cossi, 1998). More details on continuum 
models are discussed in (Tomasi, 2007). 
Explicit solvent models treat individually every molecule of the solvent. This 
allows to model direct solute-solvent interactions but, on the other hand, it leads to a 
higher computational cost. This models are usually used in molecular dynamics or 
Monte Carlo simulations. The difference between implicit and explicit solvent models 
is demonstrated in the Figure 4.1. 
Hybrid models combine the two approaches with the aim to minimize the 




Figure 4.1: Different approaches of modelling a solute in a solvent: a) the continuum approach 
– the molecule is closed in a cavity with the approximation of molecules charge distribution 
on the surface which interacts with the dielectric continuum representing the solvent; b)the 
fully solvated system – the solute is placed in a box filled with solvent molecules which are 







5 Experimental Details 
5.1 Samples  
DOPA samples are distributed in a form of white powder. In our work we used 
and studied six different DOPA samples of different origin: one non-deuterated 
sample, which is used as pharmaceutical secondary standard from Supelco: PHR1271 
– Levodopa – L-DOPA –  (I); two non-deuterated and one deuterated samples from 
Sigma-Aldrich: D9628 – 3,4-dihydroxy-L-phenylalanine – L-DOPA – (II), D9378 – 
3,4-dihydroxy-D-phenylalanine – D-DOPA – (III), and 333786 – L-DOPA-(phenyl-
d3) – 2’,5’,6’-D3-L-DOPA – (VI); and two differently deuterated isotopologues from 
Teva Pharmaceuticals CR: SD1076 – α,β-D2-L-DOPA – (IV), SD1075 – α,β,β-D3-L-
DOPA – (V). Moreover we prepared six additional deuterated analogues samples by 
isotopic exchange of easily-exchangeable hydrogens (carboxyl, hydroxyl and amine 
groups) for deuterium– samples I’ – VI’. Designations of the samples used trough out 
this work is summarized in the Table 5.1: 





























The two L-DOPA samples from Supelco and from Sigma-Aldrich gave 
identical spectra in all experiments, therefore, we summarize the results from both 
of them under designation L-DOPA, unless the distinction is required, in which 
case we refer to them as I(PHR 1271) and II(D9628), respectively.  
 
5.2 Absorption methods  
IR and VCD spectra were measured at the Institute of Physics at Charles 
University using commercial spectrometer ChiralIR-2XTM from BioTools.  
5.2.1 ChiralIR-2XTM 
ChiralIR-2XTM is a commercial spectrometer from company BioTools. It 
allows a simultaneous measurement of IR and VCD spectra in a mid-IR spectral 
range of 4000-400 cm-1. Spectrometer uses DualSourceTM radiation source which 
significantly increases signal to noise ratio (Nafie et al. 2004) and two photoelastic 
modulators (PEM) patented as a DualPEM technology which provides significant 
reduction in artefacts and improvement in baseline stability. (Biotools, Inc.) Signal 
from the sample is collected by MCT (HgCdTe) detector which requires cooling by 
liquid nitrogen to reduce the noise. The sample holder is revolving; that allows 
sample rotation during the measurement which prevents the liquid samples from 
drying out and enables elimination of artefacts in the solid samples. Picture of the 
spectrometer is in the Figure 5.1. 
 
Figure 5.1: Spectrometer ChiralIR-2XTM used for the measurement of VCD and IR spectra. 
(VCD, vibrational circular dichroism; IR, infrared) 
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5.2.1 Beta Cell 
Liquid samples for IR and VCD measurements were prepared in a setup from 
International Crystal Laboratories (ICL). We used Beta Cell (Figure 5.2) with a 
25×4 mm CaF2 windows and either a 15 μm Teflon spacer from ILC or a 6 μm 
spacer made by Vladimír Kopecký Jr., Ph.D. at the Institute of Physics of Charles 
University from BoPET (biaxially oriented polyethylene terephthalate). This 
commercially manufactured polyester with high chemical stability can be found 
under different trademarks, e.g., Mylar, Melinex, or Hostaphan. (DeMueuse, 2011). 
 
Figure 5.2: Beta Cell and a plastic cell holder from International Crystal Laboratories used for 
measurement on ChiralIR-2X 
 
 
5.2.2 ChiralIR-2XTM measurement and data treatment 
All liquid samples were measured in concentration 100 mg/ml in 1M HCl. 
Preparation of the sample was quite laborious compared to the other measuring 
techniques. First we put cleaned CaF2 window in the back part of the Beta Cell with 
the Mylar spacer on it. We made sure that the spacer fits closely to the window. 
Next, we applied 6 μl of the sample and, as carefully as possible, put the second 
window on the spacer; this was the tricky part because most of the times some 
bubbles formed in the sample and we had to dismantle the whole thing and repeat 
the procedure. Presence of the bubbles could negatively affect the measurement due 
to the water vapours which form inside of them. If there were little to none bubbles, 
we finished the assembling of the cell by screwing its front part on and attached it 
to the plastic holder by a rubber band. 
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 Setup of the spectrometer was fixed during the whole measurement: resolution 
4 cm-1, 4000 scans per block, 2-PEM MODE, and Blackman Harris function for 
apodization. The only variable thing was the number of blocks measured for each 
sample which was determined either by available time for the measurement or by 
the speed of the sample’s drying out. After every measured block a spectrum was 
obtained, meaning that every spectrum was composed from 4000 scans; 
measurement of each block took approximately one hour. 
Raw IR and VCD spectra from each run (4 – 19 blocks)   were averaged and 
the averaged data were treated by a background subtraction (signal of the Beta Cell 
filled with pure solvent) and polynomial baseline correction in GRAMS/AITM 9.2. 
The data are presented as an absorption and its difference; the conversion to a molar 
extinction coefficient and its difference would be burdened by significant errors 
originated from the uncertainty of sample’s thickness which was determined by the 
strength with witch Beta Cell was tightened, therefore was different every time.  
Measurement of the solid samples was relatively easy. A 7 mm KBr pallet 
with just a few micrograms of the sample (ratio KBr to sample was approximately 
100:1) was prepared using Mini Pellet Press (Specac Ltd) with a 2 t pressure and 
measured with the same measurement setting as the liquid samples except of the 
rotation which was slower in this case – approximately 1 rotation every 10 seconds. 
The VCD signal from the solid sample was more intense than that form the liquid 
samples and generally 3 – 4 blocks of spectral acquisition were sufficient. The 
post-processing of the spectra was similar to the liquid samples. 
 
5.3 Scattering methods  
Raman spectra were measured at the Institute of Physics of Charles University 
using two different apparatus: Raman spectrometer SPEX and Raman confocal 
microscope Alpha300 RSA. SPEX allows only liquid sample measurement, 
whereas using the Raman microscope, we were able to measure solid state samples 
as well.  ROA spectra were measured at the Department of Optics of Palacký 
University in Olomouc by Josef Kapitán, Ph.D. using his newly developed next 
generation ROA spectrometer.  
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5.3.1 Spectrometer SPEX 
Spectrometer was built at the Division of Biomolecular Physics at the Institute 
of Physics. It uses a 90˚ geometry; that means that the scatter light is being collected 
under 90˚ angle with respect to the path of the incident laser beam. Four 
wavelengths can be used for the exciting radiation: 442, 488, 514, and 532 nm. 
Scattered light travels through an edge filter to the spectrograph SPEX 270M from 
Horiba company with focal length 270 mm. Spectrograph has two grids to choose 
from; one with 1200 (g1) and one with 1800 (g2) slits/cm. Light from the 
spectrograph is detected by CCD detector with a resolution 1340×100 pixels which 
requires cooling with liquid nitrogen.  
 
5.3.2 Measurement using SPEX and data treatment  
The setup of the spectrometer was same in all experiments. We used a 532 nm, 
Nd:YAG Verdi V2 laser of power of 400 or 1000 mW. Spectra were measured in 
the range from ~75 to 2300 cm-1 using the g1 grating. Calibration was performed 
by neon lamp spectrum using the program Neocalspex2 developed by doc. Jiří Bok. 
Samples were measured in Hellma Micro-cuvette 101.015-QS, 3x3 mm, in 
approximately 80 µl volume. 
Firstly, we used SPEX to test the solubility of L-DOPA in various solvents: 
Dimethyl sulfoxide (DMSO, (CH3)2SO), tetrafluoroethylene (TFE, C2F4), 
acetonitrile (CH3CN), chloroform (CH3Cl), and methanol (CH3OH). Each solution 
was prepared in a concentration of 100 mg/ml. We then lowered the concentration 
gradually up to 12.5 mg/ml and observed that L-DOPA did not completely dissolve 
in any of the solvents. Thus, we used centrifugation to let the undissolved solutes 
sediment and to make sure that we filled the cuvette only with eventual dissolved 
sample. Systematically the pure solvent for later background subtraction was 
measured every time prior to the sample and we used the same accumulation 
settings for both. Parameters of the measurements are shown in the Table 5.2.  
Further we tested the solubility of the samples at neutral pH in distilled water 
(H2O) and heavy water (D2O) in concentration 1 mg/ml. Because the solutes did 
not dissolve completely, we used the centrifuge as in the previous case. Apart from 
the background spectra of pure H2O and D2O, we only measured the spectra for the 
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two different L-DOPA samples (PHR 1271 from Supelco and D9628 from 
Sigma-Aldrich). The parameters are shown in the Table 5.3.  
Finally we prepared all samples in concentration of 100 mg/ml in 1M HCl and 
1M DCl. Solutes easily dissolved in both solvents. We measured spectra of pure 
1M HCl and DCl and of all solutions except of D-DOPA in DCl (due to the high 
fluorescence background arising from impurities present in the sample). Parameters 
of the measurement are shown in the Table 5.4.  
 
Table 5.2: Parameters of the measurement of L-DOPA in different solvents 
Spectrometer SPEX; 532 nm; 400mW; 75-2300 cm-1 







DMSO 0.2 s 1500 5 min 
TFE 1.0 s 300 5 min 
acetonitrile 0.5 s 600 5 min 
chloroform 0.2 s 600 2 min 
methanol 3.0 s 100 5 min 
 
 
Table 5.3: Parameters of the measurement of L-DOPA in H2O and D2O 
Spectrometer SPEX 
532 nm; 400mW (H2O), 1000mW (D2O); 75-2300 cm
-1 







H2O 5 s 24 2 min 
I in H2O 10 s 120 20 min 
II in H2O 10 s 120 20 min 
D2O 5 s 24 2 min 
I in H2O 10 s 120 20 min 





Table 5.4: Parameters of the measurement of all samples in HCl 
and DClSpectrometer SPEX; 532 nm; 400mW; 75-2300 cm-1 
all solutes: c = 100 mg/ml 




HCl 5 s 24 2 min 
I 5 s 24 2 min 
II 5 s 24 2 min 
III 2 s 120 4 min 
VI 5 s 24 2 min 
V 5 s 24 2 min 
IV 5 s 24 2 min 
DCl 5 s 24 2 min 
I’ 5 s 24 2 min 
II’ 5 s 24 2 min 
VI’ 5 s 24 2 min 
V’ 5 s 24 2 min 
IV’ 5 s 24 2 min 
 
 Raw SPEX data were processed in GRAMS/AITM 9.2. A subtraction of 
respective solvent signal and polynomial baseline correction was performed in all 
spectra and they were normalized by integral intensity in the region from 300 to 
1800 cm-1.  
5.3.3 Raman confocal microscope Alpha300 RSA 
The Raman confocal microscope Alpha300 RSA from WITec Company is 
combined with atomic force microscopy (AFM) and scanning near-field optical 
microscopy (SNOM). It is equipped with excitation wavelengths 442, 532, 633, 785 
and 830 nm. It is primary suited for the imagining of cells and tissues and for 
nanoscale surface characterization. In Raman general operation modes it acquires a 
complete Raman spectra at every pixel of the image. It uses an ultra-high throughput 
spectrometer (UHTS) with focal length of 30 cm and grating 600 g/mm, which 
ensures of high quality spectra even with a low acquisition time and a low light 
intensity. The light is captured by Newton CCD detector DU970-BVF with 
resolution of 1600×200 pixels in 16×16 μm. Acquisition time used for the 
measurements was relatively short (0.10172 s) to prevent sample degradation. 
Microscope software interface is WITec Suit FOUR package which includes 
Control FOUR for measurement control and data acquisition, and Project FOUR 
for image and spectra post-processing. It enables the user to select the part of the 
sample which is going to be scanned (marked with red rectangle in the Figure 5.3) 
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and, after the spectra is acquired for every pixel, the user can choose the pixels of 
the image for the compilation of the final spectrum using filters based on selected 
spectral lines (Figure 5.4). Final spectrum is then created by averaging the spectra 
from the selected pixels and treated with the “CRR+Smooth” function for the 
removal of cosmic-rays spikes and smoothing.  
  
Figure 5.3: In WITec software Control FOUR, the user can select the desirable part of the 
image for scanning, that is marked by the red rectangle 
 
 
Figure 5.4: WITec software Project FOUR used for spectral post-processing. The window with 
spectrum shows the selected spectral ranges (blue and green bands), the three windows on the 
top show the presence of particular characteristics in the scan and the window in the bottom 




5.3.4 Sample preparation and measurement using Alpha300 RSA 
All samples were measured in solid phase, in liquid phase as 100 mg/ml solutes 
in 1M HCl, and using the drop-coating deposition Raman (DCDR) method with 1 
mg/ml solute in H2O and 0.5 mg/ml solutes in 1M HCl. For the measurements a 
532 nm laser was chosen with power of 9mW for the solid samples and DCDR 
method and 40 mW for the liquid samples, together with Carl Zeiss 50×/0.55 LD 
objective.  
Preparation of the solid samples was not laborious; we simply spread some of 
the powder on the microscope slide and chose a section of the image which was 
convenient for spectra acquisition. Ideally we tried to find a crystal that was big 
enough and that was easy to focus on. An example of that is shown in the Figure 
5.5. Scan width and height were fixed during all measurements, 20×20 μm, with 
resolution of 40×40, that is, 4 scans/μm2.  
 
 
Figure 5.5: Sample in a solid phase in Alpha300. PHR 1271 crystal selected for scanning.  
 
In liquid samples measurements 6 μl droplets were put to the microscope slit using 
micropipette. Scan width and height were fixed during all measurements, 20×20 μm, 
with resolution of 60×60, that is, 9 scans/μm2. Because the liquid samples were 
homogenous, there was no need to search for a convenient region for the measurement. 
We just had to make sure that the focus was somewhere in the sample droplet, neither 
under it nor above it.  
Drop-coating deposition Raman (DCDR) is a spectroscopic technique which 
enables measurement of low-concentration solutions. Its core is a special sample 
preparation when a microdroplet of the solution is applied to a hydrophobic plate and 
left to dry. When the droplet evaporates, the solute gets concentrated on the edges and 
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forms a ring of a high concentration (Figure 5.6). The idea is that the molecules will 
stay in their solute-like conformation, not forming crystals, hence the DCDR spectra 
will resemble the spectra of a saturated solute of the molecule. (Zhang et al., 2003; 
Filik and Stone, 2007). 
 
 
Figure 5.6: Demonstration of a DCDR sample. Typical “coffee-ring” of high sample 
concentration on the circumference is formed by dried microdroplet. Adopted from (Kuižová, 
2019). 
 
For DCDR measurement we dissolved all samples in H2O in concentration 0.5 
mg/ml and in HCl in concentration 1 mg/ml. We applied 2 μl of each solution to 
Teflon-coated plate made of stainless steel from Tienta Sciences (surface SpectRIMTM 
Slide) and let it dry for several days.  
Compared to the solid and liquid samples, it was more difficult to find an 
appropriate spot for spectra acquisition in some of the dried droplets. Eventually, we 
managed to do so in all of them except the PHR1271 in HCl. The samples, being low-
molecular species, did not tend to form nicely resolved “coffee rings” as anticipated, 
but a sort of semi-crystallized bulge.  An example of an image of DCDR sample is in 
the Figure 5.7. Because almost each sample looked differently, it was necessary to 
adjust scanned area for every single measurement. Parameters of the scanned area for 





Figure 5.7: DCDR sample of 2’,5’,6’-D3-L-DOPA in HCl (left) and H2O (right). (DCDR, 
drop-coating deposition Raman) 
 
Table 5.5: Parameters of the scanned area for DCDR samples. 










I 20×25 4 30×40 4 
II – – 30×40 4 
III 40×40 1 30×40 4 
VI 40×40 4 40×40 2 
V 20×20 5 30×40 4 
IV 15×15 9 40×40 4 
 
 
 Raw data were firstly treated in the WITec software Project FOUR as described 
above in the section 5.3.3 and then exported to GRAMS/AITM where, if needed, the 
baseline correction was performed and the spectra were normalized by the integral 
intensity from 300 to 1800 cm-1. 
5.3.5 ROA spectrometer 
Recently developed next-generation ROA spectrometer was assembled by Josef 
Kapitán, Ph.D. at the Department of Optics of Palacký University in Olomouc. It is to 
some extent similar to the commercial ROA spectrometers from Biotools. It is based 
on the principle described by W. Hug (Hug and Hangartner, 1999) and uses a system 
of rotating half-wave plates for the reduction of artefacts of the measurement. 
Spectrograph allows simultaneous measurement in the whole range of fundamental 
molecular vibrations ranging from approx. 50 to 4000 cm-1. Excitation wavelength is 
532 nm. Measurements can be performed in any of all four possible modulation 
schemes of ROA experiment (see Figure 3.9 in the chapter 3.3.3). Thanks to the high-
quality components and its overall compilation, this spectrometer overcomes attributes 
of the commercially sold spectrometers.  
5.3.6 Sample preparation and measurement using ROA spectrometer  
Spectra were measured in the SCP (scattered circular polarisation) arrangement 
using back-scattering geometry. All six samples were dissolved in 1M HCl in 
concentration 100 mg/ml and used for measurements without further treatment. About 
80 µl of each solution were put into narrow wall 3x4 mm microcuvettes (Starna 
Scientific Ltd). The total acquisition time was around 30 hours for each sample. Raw 
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spectra were calibrated using neon lamp spectrum and intensity corrected using 
spectral calibrated tungsten bulb (secondary standard).  Further, we subtracted solvent 
signal using Grams AI software and corrected baseline by polynomial splines. 
5.4 Parameters of spectral simulation 
All computations were performed using the Gaussian 09 software (Frisch et al., 
2009) by the DFT method on B3LYP or B3PW91 level of theory. We used the 6-
31+G* basis set for 1D energy scans, G-316 for 2D scans, and 6-311++G** for 2D 
scans, geometry optimization, and for the vibrational frequency calculations. In all 
cases we used water as an implicit solvent. Simulated spectral profiles were generated 






6  Results and discussion 
6.1 Solubility 
6.1.1 Solubility based on pH  
Based on the predictions from Chemicalize software, L-DOPA should exist in 
different charged states depending on pH (Figure 1.8). Different ionic forms of the 
molecule should give different vibrational spectra. The goal was to determine if it 
would be possible to prepare the samples at sufficient concentration for measurements 
of vibrational spectra of differently protonated L-DOPA forms.  
The neutral (zwitterionic) form of L-DOPA has a very low solubility, just like 
its related amino acid tyrosine. At pH ~ 6 we tried to prepare a 1 mg/ml solution in 
deionized H2O. However, even such low concentration could not be achieved; there 
still was a substantial amount of undissolved DOPA powder floating in the solution. 
Therefore, we used the centrifuge to separate the crystal form of L-DOPA from the 
potentially dissolved one and extract only the supernate for the measurement.   
Due to the very low pKa of carboxylic group (1.65), the protonated form of 
L-DOPA has to be measured at pH lower than unity. The maximum solubility is 
strongly correlated with the acidity of used solvent (HCl of various molarity) as 
evidenced in Table 6.1. In 1M HCl the sample dissolved completely within a few 
seconds to the final concentration of 100 mg/ml. Acidic L-DOPA solutions showed a 
long-term stability, enabling even time-consuming ROA measurements. 
 





1 100.0 <0.4 
0.5 74.0 0.72 
0.25 28.9 0.91 
0.1 10.5 1.15 
 
To test the solubility in a basic medium, we first prepared a suspension of 13.8 
mg of L-DOPA (I) in 138 μl of distilled H2O which we then gradually diluted by 2.5 
M NaOH solution and observed if L-DOPA dissolved with an increasing 
concentration. After first 5 μl of NaOH was added to the suspension, the white 
undissolved crystals of L-DOPA changed colour to a light brown indicating an 
oxidation of L-DOPA which, however, remained undissolved. We added up to 1.05 
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ml NaOH to the suspension but we observed no significant change in solubility. The 
sedimented undissolved crystals of L-DOPA turned even darker brown and the 
solution turned light brown indicating that a little amount of L-DOPA dissolved. 
Potentially, it would be possible to dissolved L-DOPA in degassed water in a 
protective atmosphere to prevent the oxidation. Nevertheless, the following 
spectroscopic measurements would also have to be performed in the protective 
atmosphere which would be very complicated. Moreover, in basic pH there are three 
ionisable functional groups (hydroxyl groups and amino group) which increase the 
number of differently charged L-DOPA forms present in the solution at basic pH and 
would complicate further analysis. 
 
Figure 6.1: Comparision of L-DOPA Raman spectra in acidic and neutral pH. 
 
The final Raman spectra for neutral (zwitterionic) and acidic (cationic) form of 
L-DOPA (I) in aqueous solution are shown in the Figure 6.1, lower and upper panel, 
respectively. The concentration of L-DOPA in 1M HCl was 100 mg/ml. Thanks to the 
fact that HCl is a strong acid and, therefore, it dissociates completely in aqueous 
solution, Raman spectrum of 1M HCl appears to be similar to those of pure deionized 
water. In acidic medium L-DOPA dissolves easily and the intensity of its spectra is 
comparable with that of the pure solvent, however in neutral pH it barely dissolves and 
the intensity of its spectra is approximately thousand times lower than that of the pure 
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solvent. Based on that we estimate that the concentration of L-DOPA in H2O was 
approximately 0.01mg/ml.  Still we were able to obtain nicely resolved spectrum with 
~ 30 resolved spectral bands (identified using the second derivative of the 
spectrum).Total acquisition time of L-DOPA spectra was 2 minutes in acidic medium 
and 20 minutes in pH-neutral medium.  
 Due to the relatively low signal to noise ratio of L-DOPA spectrum in neutral 
pH, it is not possible to fully qualitatively compare it to the spectrum in acidic pH. 
Overall spectral shape of both L-DOPA forms appears to be similar. In the lower 
spectral region it seems that peak at 786 cm-1 in 1M HCl is actually composed of three 
whereas corresponding peak in H2O at 784 cm
-1 is a singlet. On the other hand, in the 
higher spectral region the three peaks in HCl, 1354, 1446 and 1626 cm-1, seem to have 
split up each into more peaks. However, in the region above 1560 cm-1 there is a 
residual water signal left in the L-DOPA spectrum in H2O which makes it difficult to 
distinguish individual peaks. Some of the peaks seem to be shifted in the order of units 
of cm-1 but this could be credited to the difficulty of distinguishing the exact position 
of the peaks thanks to the low intensity. The only significant shift is that of the peak at 
719 cm-1 in 1M HCl which in H2O changed its position to 727 cm
-1. The more detailed 
vibrational analysis will be shown in the section 6.6.3. 
 
6.1.2 Solubility in various solvents 
It became clear already before that L-DOPA is soluble in a strong acidic medium 
which allowed for relatively fast spectral acquisition in the order of minutes. However, 
the zwitterionic form is almost insoluble. We wondered if it was possible to use other 
solvents for measuring the spectrum L-DOPA at neutral pH.  
Therefore, we tried to prepare solution of L-DOPA of 100 mg/ml concentration 
in five different organic solvents. Unfortunately, L-DOPA did not dissolve in any of 
them so we lowered the concentration by gradually increasing the volume of the 
solvents. A partial dissolution was visible only when the concentration of 12.5 mg/ml 
was reached. Nevertheless, the real concentration of dissolved L-DOPA was much 





Table 6.2: Testing of L-DOPA solubility in different solvents. 
               concentration 
(mg/ml) 
solvent 
100  50 25  12.5 
DMSO × × × partially 
TFE × × × partially 
acetonitrile × × × minimally 
chloroform × × × minimally 
methanol × × × minimally 
 × means that dissolution was not visible, “partially” marks the situations where only partial 
dissolution was observable. DMSO, dimethyl sulfoxide; TFE, tetrafluoroethylene 
 
Samples were centrifuged and supernates were used for Raman spectra 
measurements. The background subtraction and baseline correction was performed in 
all acquired spectra. The solute’s signal intensity was in most cases very close to the 
resolution limit and, moreover, most of the solvent’s Raman spectra were generally 
more than thousand times stronger than spectra of the solute and overlapped with it 
strongly; this made it impossible to perform the subtraction without any solvent 
residua. We could improve the quality of spectra by increasing the acquisition time or 
the number of acquisitions but our goal was to explore if in some of these solvents the 
acquisition of L-DOPA spectra could be performed as fast and easily as in HCl.  We 
concluded that all of the used solvents failed to meet this condition.  
Considering the above said nature of resulting spectra, we demonstrate only those 
of TFE and DMSO solutions because in other solvents the signal of L-DOPA was not 
distinguishable. Spectra are shown in the Figure 6.2. It presents the spectrum of 
L-DOPA in TFE and DMSO with total acquisition time of 5 minutes after the 
background subtraction and baseline correction and spectra of the pure solvents. The 
parts of L-DOPA spectra with high residual solvent signals were omitted.  In both 
cases the significant residual solvent signal is present.  The signal of L-DOPA in 
DMSO exhibits higher signal to noise ratio, based on that we conclude that L-DOPA 
dissolves better in it this solvent.  
The comparison of L-DOPA (I) obtained in TFE and DMSO with that measured 
in water is shown in Figure 6.3. We have identified 14 peaks in H2O which are 
observable at least in one of the other solvents; 5 of them are observable in both (508, 
784, 824, 1293, and 1626 cm-1), 6 are observable only in DMSO (423, 593, 855, 1169, 





Figure 6.2: Raman spectra of L-DOPA in tetrafluoroethylene (TFE) and dimethyl sulfoxide 
(DMSO) compared to the spectra of pure solvents. Parts of the spectra with strong residual 




Figure 6.3: Comparison of L-DOPA (I) Raman spectra measured in different solvents. 





To sum up, L-DOPA dissolves very poorly in basic and neutral pH. Moreover, 
in the basic pH it oxidizes, so there is no point in measuring the spectra. We managed 
to obtain (with some difficulties) Raman spectrum of zwitterionic form in H2O which 
was approx. 10-4 times less intensive than that in HCl. Based on that we estimate that 
the solubility in H2O is also approx. 10
-3 lower than in 1M HCl (≈0.01 mg/ml) which 
is too low for any VOA measurements. L-DOPA dissolved poorly or not at all in 5 
different pH neutral solvents.  Cationic form of L-DOPA was found to be easily 
soluble in concentrations enabling further ROA and VCD measurements (100 mg/ml 
in 1M HCl, 70 mg/ml in 0.5M HCl). 
6.2  Raman spectra of different phases 
In this section we present the Raman spectra of samples I - VI measured in 
different phases by different spectrometers. We compare (i) the measurements in a 
liquid state in acidic medium (1M HCl) from SPEX and Alpha 300, (ii) the spectra of 
crystal phase, liquid phase and “dried” state (DCDR technique) from Alpha 300, and 
(iii) the differences between DCDR spectra of neutral (zwitterionic, neat aqueous 
solvent) and cationic (1M HCl aqueous solvent) form of various samples. Spectra of 
the non-deuterated samples are presented in the Figure 6.4 and spectra of the 
differently deuterated samples in the Figure 6.5. Upon deuteration, new peaks of C-D 
vibrations appear around 2300 cm-1 making the spectra of deuterated samples easily 
distinguishable. The resulting spectra are normalized based on integral intensity of 300 
to 1800 cm-1 spectral interval and they are shown from 300 cm-1 because at a lower 
frequency-shifts the signal from Rayleigh scattering is still dominant. 
Our first goal was to qualitatively compare liquid phase spectra measured by 
SPEX and Alpha 300 instruments (purple and blue lines in the Figure 6.4 and Figure 
6.5). The main difference between SPEX and Alpha 300 is that the first spectrometer 
(equipped with g1 grating – 1200 slits/cm) acquires the spectra in the region from 
approximately 70 to 2400 cm-1; thus, it does not include the C-H stretching vibrations 
which occur around 3000 cm-1. (Their recording would require to reverse the grating 
and to stitch together the recorded spectra.) Spectra form Alpha 300 reach from 0 up 
to 3600 cm-1, hence, they cover the whole vibrational spectral range. Another 
difference is that the signal to noise ratios of resulting SPEX spectra are higher than 
those of spectra acquired with Alpha 300, thanks to the larger volume of the sample in 
laser focus. This becomes evident mainly in the cases of liquid D-DOPA (III, see 
60 
 
Figure 6.4 lower panel) and α,β,β-D3-L-DOPA (V, see Figure 6.5 middle panel) 
spectra. These samples were contaminated by an impurity which, particularly when 
dissolved, showed a strong fluorescence with which was easier to cope with in the 
post-processing of the spectra from SPEX. Also spectra from SPEX manifested a 
slightly better spectral resolution enabling the distinguishing of delicate spectral 
features (small bands and shoulders; see e.g. Figure 6.5 lower panel around 800 cm-1, 
marked by arrows). Apart from these fine differences, the resulting spectra of liquid 
samples from both spectrometers are qualitatively identical.  
The second goal was to determine the differences among spectra from crystal, 
dried and liquid phase (blue, lime, and maroon lines in the Figure 6.4 and 6.5). The 
main difference is that the peaks of the liquid-state spectra are generally wider and, 
moreover, those peaks which are close to each other in the crystal-state tend to merge 
and became undistinguishable. This happens because the positions of the atoms in a 
crystal are better defined than in a soluted state and, as a result, so are the frequencies 
of their vibrations. This is clearly observable in the area around 750 cm-1. Another 
notable difference in the liquid spectra is an appearance of a peak around 1750 cm-1 
corresponding to the COOH group vibration, which is not present in the spectra of 
crystalline phase in which L-DOPA remains in its zwitterionic form. (Mostad et al., 
1971) 
The third goal was to determine the applicability of DCDR (drop-coating 
deposition Raman scattering) technique to the measurements of differently charged 
DOPA samples (lime and orange lines in Figure 6.4 and Figure 6.5). This was 
motivated by the effort to enable simple measurement of DOPA samples in neutral 
(zwitterionic) form. In DCDR the spectra recorded from a “coffee ring”, which 
represents the desired dried state of the sample, usually resemble the spectra obtained 
from liquid phase at much higher concentration. However, our observations were (with 
a few exceptions) different. DOPA samples did not form the desired pattern during the 
drying-out process (compare Figure 5.6 and Figure 5.7). All of them tended to form 
semi-crystallized bulges probably due to their low-molecular nature. This tendency 
was even more pronounced for the samples in acidic solvent. In most cases the 
recorded DCDR spectra looked like a superposition of the crystal and liquid-phase 
spectra with a prevailing solid phase component; this was nicely evidenced by the 
shape of the signal in the C–H stretching region (around 3000 cm-1). The only 
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exception was DCDR spectra of 2’,5’,6’-D3-L-DOPA in H2O which possessed 
characteristics of liquid-phase Raman spectra.  
 
 
Figure 6.4: Raman spectra of three non-deuterated DOPA samples as measured by different 









Figure 6.5: Raman spectra of three differently deuterated DOPA samples as measured by 





In general, the DCDR technique was not found particularly beneficial for the 
study of DOPA samples due to their problematic drying out. However, for 
2’,5’,6’-D3-L-DOPA (VI) in H2O we obtained a fine quality DCDR spectrum which 
allowed identification of differences between spectra of differently charged forms (see 
Figure 6.6). It is evident that spectra of the zwitterionic and cationic form of (VI) are 
quite similar. The most noticeable differences are (i) the appearance of the 1733 cm-1 
peak in the spectrum of cationic form of L-DOPA (top blue line) corresponding to the 
COOH group vibration and (ii) the change of the relative intensity of the bands 
between 1320 – 1450 cm-1 where C–O–H bending vibrations occur. Further, there are 
peaks of low intensity at 775, 950, and 2873 cm-1 in the spectrum of cationic (VI) 
which cannot be observed in the zwitterionic form.  
 
 
Figure 6.6: Comparison of the Raman spectra of 2’,5’,6’-D3-L-DOPA in acidic medium (top 
line) and pH neutral medium (bottom line). 
 
In conclusion, on one hand, spectra from SPEX show a greater signal to noise ratio 
than spectra from Alpha 300, but on the other hand, they do not cover as big spectral 
range. Nevertheless, in the region covered by both spectrometers, the spectra are 
quantitatively similar. Spectra of the liquid samples differ mainly in the width of the 
bands which is greater than in the case of the liquid spectra thanks to the merging of 
the peaks which are close together, and in the appearance of a few new peaks around 
1750 cm-1 related to the COOH vibrations. DCDR technique has been found not 
suitable for the study of DOPA molecule because the samples did not dried out in a 
proper “coffee ring” shape but rather recrystallized thanks to their low molecular 
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weight. However, the spectra of cationic and zwitterionic forms of DOPA samples 
appear to be rather similar, as evidenced on the example of (VI) in the Figure 6.6.  
 
6.3 Comparison of different non-deuterated DOPA samples 
In this section we compare the non-chiral spectral properties of three different 
non-deuterated samples of DOPA (I, II, and III) with the intention to verify in which 
cases it is possible to interchange their spectra. In the Figure 6.7 we present the 
comparison of Raman and IR spectra of crystal phase and in the Figure 6.8 the 
comparison of Raman and IR spectra of liquid phase of DOPA. 
The Raman spectra of crystalline samples (Figure 6.7) slightly differ from each 
other. Each spectrum is quantitatively unique in the region of C–H vibrations (around 
3000 cm-1), however, qualitatively the spectra of (I) and (II) are similar. On the other 
hand, the doublet which is present in the spectra of (I) and (III) around 2990 cm-1 
seems to merge in the spectrum of (II) into one peak. In the fingerprint region all three 
spectra are quantitatively similar; all the peaks are present in each spectrum, they only 
differ in their intensities. However, in the IR spectra, measured on ChiralIR-2X 
spectrometer, no differences are apparent. One possibility is to assign the variations in 
the crystal spectra to a slightly different crystalline structure of each sample caused by 
a different procedure of preparation, which is further confirmed by the fact that upon 
dissolution the differences disappear. In that case we would expect the IR spectra of 
crystal state to differ as well. They, however, do not. That is why we assume that the 
difference is caused by the low acquisition time of the spectra. 
Both, Raman and IR spectra of the liquid samples (Figure 6.8) are quantitatively 
and qualitatively similar, virtually identical.  
In conclusion, Raman spectra of the two non-deuterated L-DOPA samples (I and 
II) and the non-deuterated D-DOPA sample (III) differ only in the crystalline form. 
IR spectra of these samples are identical. Raman and IR spectra of the three liquid-state 
samples are also identical, therefore, it is safe to use only one of them as a 






Figure 6.7: Crystal-phase Raman and IR spectra of three non-deuterated samples 
 
 




6.4 Comparison of Raman and IR spectra of differently deuterated 
samples  
In this section we compare Raman and IR spectra of the samples dissolved in 1M 
HCl to those dissolved in 1M DCl. In 1M DCl solution a relatively fast exchange is 
happening between the hydrogen and deuterium atoms on the “soft” positions in the 
molecule (OH and NH3
+ groups change into OD and ND3
+ groups) which is reflected 
in the changes of Raman and IR spectra (Figure 6.9). The observed changes can be 
divided into six main groups:  
(i) The ν(O-D) vibrations observed in Raman spectra as broad overlapping bands 
at approximately 2170 cm-1 (hydroxyl in the carboxyl group)  and 2250 cm-1 
(hydroxyls at the aromatic ring). The relatively low intensity and broad character of 
these bands are caused by the strong interactions of hydroxyl groups with the solvent. 
In the case of deuterated L-DOPA analogues, the ν(O-D) vibrations are partially 
overlapped with the more pronounced ν(C-D) vibrations. (ii) The ν(N-D3) vibrations, 
particularly the symmetric one, evidenced as a very weak (but recognizable) band at 
2020 cm-1. This band is also widened thanks to the strong interaction with the solvent. 
(iii) Slight ~ 4 cm-1 shift of ν(C=O) vibrations at ~1730 cm-1, caused by the 
hydrogen/deuterium exchange at the carboxyl group, observable in both IR and Raman 
spectra. (iv) Sharpening of the band at ~1610 cm-1 in Raman spectra and a slight shift 
of bands at ~1610 and 1530 cm-1 in the IR spectra. These bands correspond to the 
asymmetric (higher wavenumber) and symmetric (lower wavenumber) 
δ(N-H3)/δ(N-D3) deformations which are only weakly evidenced in Raman but easily 
traceable in IR. (v) The variations of both IR and Raman spectral shapes in 1180 – 
1320 cm-1 region correspond to the ν(C-OH)/ν(C-OD) and δ(C-OH)/δ(C-OD) 
vibrations. (vi) Sharpening of the band at ~790 cm-1 in Raman spectrum corresponds 
to the aromatic ring δ(CCC) breathing vibrations and δ(OCO) vibrations.  
In summary, the hydrogen-deuterium exchange on the “soft” positions enables 
relatively easy empirical identification of the corresponding spectral bands especially 







Figure 6.9: Raman and IR spectra of all L-DOPA samples in 1M HCl and 1M DCl where the 
interchange of hydrogen atom for the deuterium atom is happening on the soft positions. 
(br. – breathing vibration; * – artefact) 
 
 
Spectral manifestations of the deuteration on the “hard” (carbon) positions within 
L-DOPA molecule is considerably more distinctive as demonstrated in the Figure 6.10 
where Raman signals of compounds (I), (IV), (V), and (VI) are compared. As 
expected, the most significant changes are found in the region of C–H and C–D 
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stretching vibrations. The changes in the fingerprint region are more subtle (with 
exception of the compound VI which is deuterated on the aromatic ring) which means 
that the overall spectral shape in this region is given mainly by the bands that 
correspond to the phenyl group vibrations.  
 
Figure 6.10: Raman spectra of differently deuterated samples in 1M HCl.  
 
Thanks to the known deuteration patterns we may empirically assign all bands in 
the C–H and C–D stretching region (A – H): bands G and H at 3034 and 3081 cm-1 
move upon deuteration of the phenyl ring to 2262 and 2287 cm-1, respectively 
(compare the blue (VI) and the maroon (I) lines in the Figure 6.10). These bands thus 
certainly correspond to the out-of-phase and in-phase C–H stretching vibrations at the 
phenyl group, respectively. Remaining three bands with a lower wavenumber then 
have to correspond to different in-phase and out-of-phase combinations of C–H/C–D 
stretching vibrations at C2/α and C3/β. A comparison of the spectra of L-DOPA samples 
IV and V (orange and lime line in the Figure 6.10), which are deuterated at aliphatic 
part of the molecule (C2/α and C3/β), enables further assignment. When all three 
hydrogens are exchanged for deuteria (sample V, lime line), the corresponding spectral 
pattern composed of the peaks A, B, and E remains similar to that in the non-deuterated 
L-DOPA (I), it is only shifted to the lower wavenumbers. However, when only one 
hydrogen at C3/β is exchanged for deuterium, the characteristic pattern vanishes; there 
is a single band C with a shoulder F at the C–D stretching region and a single band D 
in C–H stretching region which position corresponds to the peak B in the spectrum of 




Table 6.3: Empirical assignment of C–H and C–D vibrations. 
peak I IV V VI Assigment 
A 2870 cm-1  2104 cm-1 2872 cm-1 ν(C-H2) /ν(C-D2) C3 ss 
B 2941 cm-1  2173 cm-1 2944 cm-1 ν(C-H) / ν(C-D) C2  
C  2186 cm-1   ν(C-D) C3, ν(C-D) C2 ip 
D  2959 cm-1   ν(C-H) C3 
E 2977 cm-1  2235 cm-1 2979 cm-1 ν(C-H2) as / ν(C-D2) as 
F  2236 cm-1 sh   ν(C-D) C3, ν(C-D) C2 op 
G 3034 cm-1 3034 cm-1 3035 cm-1 2264 cm-1 ν(C-H) ip / ν(C-D) ip phenyl 
H 3081 cm-1 3080 cm-1 3082 cm-1 2288 cm-1 ν(C-H) op / ν(C-D) op phenyl 
ν – stretching vibration; ip – in phase; op – out of phase 
 
More precise assignment of vibrations in the fingerprint region is though 
impossible merely on the empirical basis, therefore we shifted from the purely 
experimental investigation to the QM simulations of vibrational profiles. 
 
6.5 VOA spectra of L-DOPA  
In this section we present ROA spectra of liquid samples measured in Olomouc 
by RNDr. Josef Kapitán, Ph.D. along with their parent Raman spectra. We also 
present the IR spectra of solid and liquid form of L-DOPA which were measured 
simultaneously with VCD on the spectrometer ChiralIR-2XTM at the Institute of 
Physics in Prague. Unfortunately, measurement of the VCD was accompanied by 
some difficulties which we discuss below in the section 6.5.1.  
Figure 6.11 shows the Raman, ROA and IR spectra of L-DOPA with assigned 
vibrational modes according to the Table 6.6 (section 6.6.3). Some of the computed 
modes are not recognizable in the Raman spectrum. This is caused firstly by the 
fact that the resolution is not high enough and the peaks of the vibrations with close 
frequencies merge together, and secondly by the interaction of L-DOPA molecule 
with the solvent through the hydrogen bonds which results in the widening of the 
bands. The second problem concerns mainly the OH and NH vibrations in the 
higher spectral region above 3200 cm-1. In total, we were able to distinguish ~60 
spectral features in the Raman spectrum in the region 100-3900 cm-1 using the 
second derivative of the spectrum. In ROA the number of identified bands was 
lower (~40) due to the unresolved features in the CH/NH/OH stretching region 
(above 2750 cm-1) and higher noise level. In IR only 22 individual spectral features 
(bands and shoulders) were found as the spectrum was recorded only in the 900-
1900 cm-1 spectral region. Obtaining of the reasonable liquid phase VCD spectrum 
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was extremely difficult and demanding. Even though both of the DOPA 
enantiomers were available, only ~5 spectral features could be assigned with 
certainty (we discuss this in detail in the following subsection 6.5.1). 
The quality of the measured Raman and ROA spectra was exceptionally good 
and enabled detailed interpretation and assignment of individual vibrational 
features in the whole region of fundamental molecular vibrations. It should be 
emphasized that ROA instrument in Olomouc routinely enable reproducible 
measurement in both CH stretching region (2700-3900 cm-1) and low-wavenumber 
(terahertz) region (down to ~75 cm-1), which is unparalleled to other ROA 
instruments both commercial or home-build. CID (ROA to Raman signal ratio) is 
relatively low for L-DOPA, the most intense bands reach the value ~4∙10-4 (~6∙10-5 
in CH stretching region). IR and VCD spectra have mainly supportive and 
complementary character to Raman and ROA data. IR absorbance in 1M HCl was 
very low even at 100mg/ml sample concentration (6 μm spacer) with maximum 
about 0.15. The g factor ≤ 9∙10-5 shows that VCD signal was also rather low when 
compared to IR, which made its acquisition quite difficult. 
 
Figure 6.11: VOA spectra of L-DOPA. Numbering of the vibrational modes corresponds to 
the Table 6.6. VCD spectra were acquired as a half of the difference between spectrum of 




6.5.1 VCD spectra of DOPA  
The motivation was to measure the VCD spectra of both enantiomers of 
non-deuterated DOPA and then measure the spectra of other deuterated analogues 
using the same methodology. Especially, we hoped to get the spectrum of 
α,β-D2-L-DOPA which would help us to determine the enantiomeric purity of the 
sample at the second chiral centrum Cβ. With a huge help of Vladimír Kopecký Jr., 
Ph.D. we attempted to measure VCD spectra of L-DOPA and its deuterated derivatives 
in solid and liquid state. In this section we focus on the results of non-deuterated 
samples, deuterated samples are discussed in the section 6.7. 
The measurement of the solid-state samples went quite smoothly and the 
post-processing of the spectra was not a problem, we present the results in the Figure 
6.12. The post-processed spectra are shown in the first panel along with half of their 
sum which indicates which parts of the spectra are burdened with high inaccuracy; 
these are the areas around 1150 – 1200 cm-1 with a strong KBr signal, but then also 
the areas around 1250 and 1550 cm-1 where the artefacts cannot be explained by the 
KBr signal. The middle panel shows the IR spectrum of L-DOPA and in the bottom 
panel are the processed spectra of L- and D-DOPA after artefact subtraction (i.e. 
calculated as a half of the difference between the measured L-DOPA and D-DOPA 
spectrum and vice versa) However, it is evident that in case both enantiomers of the 
studied substance would not be for disposal, the acquired VCD spectra would be 
burdened by significant errors. 
On the other hand, the measurement of the liquid samples was more complicated. 
Firstly we measured all samples I – VI in concentration of 100 mg/ml in 1M HCl with 
the use of 6 μm Mylar spacer where we faced several problems starting with the sample 
preparation, where we had to work very carefully not to leave any air bubbles in the 
cuvette. We used 6μl of the sample each time. The next obstacle was the drying out of 
the sample which caused a drop in the intensity of the signal after a few hours 
(generally 5). However, the main problem was that the VCD signal of DOPA is simply 
too weak and not even 15 hours of measurement were enough to obtain a nice 
spectrum. Moreover, the VCD signal had a strong background which was not caused 
by the solvent and due to which it was impossible to determine the baseline, and 
several artefacts which were not reducible by the spectral subtraction. While 
attempting to process the spectra, we realized that the results are unusable, and we 
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decided to try a 15 μm Teflon spacer instead of the 6μm Mylar one, which caused the 
appropriate increase of absorbance. However, the absorbance of the solvent (water) 
was also increased by the same factor which led to the higher noise in the 1550–1750 
cm-1 region. Using the Teflon spacer we measured only samples I and III (L-DOPA 
and D-DOPA) and we were able to gain reasonably looking and reproducible signal of 
the two enantiomers in the 1000 – 1550 cm-1 region (Figure 6.13). The signal was very 
noisy above that region due to the high absorbance of the solvent (water). The artefact 
from CaF2 cuvette is visible around 1170 cm
-1.  Despite all our efforts, we were able 
to assign only several bands in area from 1200 to 1450 cm-1 (Figure 6.11 and Figure 
6.27). On the positive side, spectral features in this region correspond to the simulated 
VCD spectra quite well. Their comparison is given in the section 6.7.  
 
Figure 6.12: Solid phase VCD spectra of the two enantiomers of DOPA and their differential 
spectrum (top), overlapping IR spectra of both enantiomers (middle), and solid phase VCD 
spectra of DOPA enantiomers after artefact spectrum subtraction (bottom). * – artefact from 




Figure 6.13: Liquid state VCD (top) and IR (bottom) spectra of the two enantiomers of DOPA 
in a 100 mg/ml solution in 1 M HCl. * – artefact from CaF2, ** – region of high water 
absorbance burdened with high noise signal.   
 
In conclusion, the Raman, ROA and IR experimental spectra of L-DOPA solution 
in 1M HCl were measured without big complications, except the fact that ROA 
measurement was quite time consuming (~ 30 hours for one spectrum). All of them 
are of such good quality that it is possible to compare them to the simulated spectra 
and assign the majority of spectral features to the specific vibrational motions. On the 
other hand, measurement of the VCD spectra of liquid samples yielded ambiguous 
results. VCD signal of DOPA is undoubtedly very low (at least 104 times lower than 
IR absorption signal) and it is burdened with low signal-to-noise ratio.  The results 
were reproducible after using a 15 μm Teflon spacer. The down side of such thick layer 
of sample is, that it made it impossible to obtain the spectrum in the 1550 – 1750 cm-1 




6.6 Ab initio calculations of L-DOPA   
In this section the process of calculation of Raman, ROA, IR and VCD spectra is 
shown. The conformational analysis was performed on the cationic form of L-DOPA 
and the calculation was performed by Gaussian 09 software (Frisch et al., 2009). 
6.6.1 Conformational analysis  
Levodopa is a small and flexible molecule, therefore, it has more possible 
conformations which can coexist in the aqueous solution. To find the most probable 
conformers, we defined 5 torsion angles in the cationic form of L-DOPA (α-γ) (see 
Figure 6.14) and we performed a scan of the molecule’s energy with a step of 10° for 
each defined angle, keeping the rest of the molecule rigid. We used the functional 
B3LYP, 6-31+G* Pople basic set, and water as an implicit solvent in C-PCM theory. 
The results of this process is shown in the Figure 6.14. The description of the torsion 
angles and their positions in the local energy minima is given in the Table 6.4. While 
the energy of the molecule changes smoothly with the rotation of the angles α, β, and 
δ, this is not the case with the other two angles. During the rotation of γ and ε at one 
point the energy of the molecule decreases rapidly (see orange and green lines marked 
by triangles in the Figure 6.14). In case of γ, this is accompanied by the change of the 
angle β and in case of ε by the change of δ. Therefore, we run the scan also backwards 
(lines marked by circles in the Figure 6.14) to confirm the positions of the located 
potential energy minima. While the energy minima of forward and backward scans 
align well for α, β, δ, and ε, in case of γ the C3 minimum in the backward scan is shifted 
from 132° to 102°. 
 
 
Table 6.4: Angle’s values at the local energy minima of L-DOPA and their description. 
angle 
# of energy minima 
and the angle 
position 
description 
α 2: -35°, 155° rotation of the carboxylic group 
β 3: -170°, -60°, 69° rotation of the alaninyl chain 
γ 3: -79°, 72°, 132° rotation of the fenyl group 
δ 2: 0°, 180° rotation of the C3’ hydroxylic group 






Figure 6.14: Definition of five torsion angles within L-DOPA structure characterising its 
conformation and the results of the 1D potential energy scans along the change of each of the 
angles with 10° step.  
 
In order to estimate more accurately how the torsion angles interfere with one 
another, we run three 2D scans during which the neighbouring pairs of angles on the 
alaninyl chain: [α, β] and [β, γ] and the pair of angles defining the steric position of 
hydroxyls on the phenyl ring, [δ, ε], were simultaneously changed with a 10° step. The 
scans were calculated on the B3PW91/6-31G level of theory. Resulting 2D sections of 
the whole molecular potential energy surface along with the positions of the angles at 
local energy minima are shown in the Figure 6.15. Red areas correspond to the 
arrangement of the angles resulting in the lowest relative energy of the molecule. Local 
energy minima are marked with capital Greek letters: Σi= {[αi, βi]}, Δi={[βi, γi]}, and 





Figure 6.15: 2D potential energy scans of L-DOPA molecule covering [α, β], [β, γ], and [δ, ε] 
pairs of dihedral angles together with the overview of the all located local energy minima. 
 
Despite the 1D scan revealed energy minima for two orientations of each OH 
group on the phenyl ring (that is for the angles δ and ε), which means that theoretically 
there are 4 possible preferred mutual positions, 2D scan showed only three of them. 
The most unstable arrangement (δ=ε=180°), where the OH groups are facing towards 
each other, was not evaluated as an energy minimum during the 2D scan. Yet, from 
the molecular dynamics provided by Mgr. Jakub Klener at the Faculty of Mathematics 
and Physic of Charles University we know that the occurrence of these kind of 
conformers is non-zero. The actual overall occurrence of the conformers is affected by 
the interactions of the hydroxyl groups with the solvent via hydrogen bonds for which 
we did not account in the computation. Nevertheless, we assume that the missing 
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conformers do not significantly affect the accuracy of the results due to their low actual 
occurrence.   
The approximate values of individual angles in the local minima found by 2D scan 
are: α ∊ {-70°, 140°, 75°}, β∊{-170°,-70°,70°}, γ∊{-100°, -70°, 75°, 100°}, 
δ∊{0°,180°}, and ε∊{0°,180°}. However, we do not need to take into account all 
possible combinations (4×3×4×2=96) of these angles for further conformational 
analysis because, if we look closely, some of them are already eliminated (e.g. from 
β⊗γ=3×4=12 possible combinations of β and γ, only six of them correspond to one of 
the minima). For further analysis we had chosen 54 (=6×3×3) conformers: Δ⊗α⊗Ω; 
thus we added only one extra combination of [α,β] which was not present in the found 
minima and that was [75°,-75°]. We named the conformers DOPAH_XYtc/cc/ct, 
where X∊{1,2,3} and marks the value of α: α1=-70°, α2=140°, α3=75°, Y∊{1,2,3,4,5,6} 
and marks the combination of β and γ: Δ1 … Δ6, and t and c stand for trans (180°) and 
cis (0°) and denote the  rotation angles  δ  and ε, respectively. For these conformers 
we performed geometry optimization using the B3PW91 functional, 6-311++G** 
Pople basis set and water as an implicit solvent in C-PCM theory. Resulting 
conformers are divisible into three groups based on the orientation of the OH groups 
on the phenyl ring: Ω1, Ω2, and Ω3) thanks to the fact that their rotation is adiabatically 
separable from the rotation of the torsion angles at the alaninyl chain. Accordingly, we 
determined the percentage occurrence of each conformer, both within the respective 
Ω group and in total, based on the conformer’s energies. The results are shown in the 
Error! Reference source not found.. 
The interaction of the OH groups of L-DOPA with the water molecules of the 
solvent, which is omitted in the computation, plays an important role in the stability of 
the conformers. That is why, even though the computed overall joint occurrence of the 
12 conformers from cc (Ω3) group is merely 1.7%, we did not discard them from the 
spectral analysis. We assume that the actual fraction of cc group is higher thanks to 
the hydrogen bonds which it forms with the solvent. As we will see in the next section, 











Table 6.5: Most probable conformations of L-DOPA  
conformer 
α β γ δ ε 
overall within Ω group 
ΔE ΔE0 ΔH ΔG η ΔE ΔE0 ΔH ΔG η 
(°) (kcal/mol) (%) (kcal/mol) (%) 
      
         
 
DOPAH_11tc -73 -175 -77 -179 1 0.0 0.0 0.2 0.0 22.7 0.0 0.0 0.0 0.0 42.2 
DOPAH_12tc -73 -175 102 180 0 0.3 0.5 0.6 1.0 14.3 0.3 0.5 0.4 1.0 26.7 
DOPAH_14tc -52 -68 82 179 0 0.7 0.9 0.9 1.5 7.4 0.7 0.9 0.7 1.5 13.9 
DOPAH_13tc -52 -67 -97 -179 1 0.9 1.1 1.1 1.6 5.2 0.9 1.1 0.9 1.6 9.7 
DOPAH_31tc 116 177 -74 -179 1 1.7 1.8 1.9 2.0 1.3 1.7 1.8 1.7 2.0 2.5 
DOPAH_22tc 117 176 100 180 -1 2.0 2.1 2.2 2.4 0.8 2.0 2.1 2.0 2.4 1.6 
DOPAH_16tc -87 66 72 179 0 2.2 2.4 2.5 2.8 0.5 2.2 2.4 2.4 2.8 1.0 
DOPAH_34tc 132 -70 81 180 0 2.3 2.7 2.6 3.2 0.4 2.3 2.7 2.4 3.2 0.8 
DOPAH_15tc -88 66 -104 -180 0 2.3 2.7 2.7 3.1 0.5 2.3 2.7 2.5 3.1 0.9 
DOPAH_33tc 131 -70 -97 -179 0 2.5 2.8 2.8 3.5 0.3 2.5 2.8 2.6 3.5 0.6 
DOPAH_36tc 86 62 73 179 0 3.6 3.7 3.8 3.9 0.1 3.6 3.7 3.6 3.9 0.1 
DOPAH_35tc 85 62 -104 -180 0 3.7 4.0 4.1 4.2 0.0 3.7 4.0 3.9 4.2 0.1 
  
     
   Σ 43.5    Σ 100 
DOPAH_11cc -73 -175 -78 0 0 1.8 2.0 2.1 2.4 1.0 0.0 0.0 0.0 0.0 44.1 
DOPAH_12cc -73 -175 103 -1 0 2.2 2.5 2.5 2.9 0.6 0.3 0.5 0.4 0.5 25.4 
DOPAH_14cc -51 -68 83 -1 0 2.5 2.8 2.7 3.5 0.3 0.7 0.8 0.6 1.1 13.8 
DOPAH_13cc -51 -68 -98 1 0 2.8 3.1 3.0 3.7 0.2 0.9 1.0 0.9 1.3 9.1 
DOPAH_31cc 107 179 -76 0 0 3.5 3.8 3.8 3.8 0.1 1.7 1.7 1.7 1.4 2.6 
DOPAH_22cc 109 179 106 0 0 3.8 4.1 4.2 4.4 0.0 2.0 2.1 2.1 2.0 1.6 
DOPAH_16cc -87 66 73 -1 0 4.1 4.3 4.4 4.6 0.0 2.3 2.3 2.3 2.2 1.0 
DOPAH_34cc 133 -70 81 -1 0 4.2 4.5 4.5 5.1 0.0 2.3 2.5 2.3 2.7 0.8 
DOPAH_15cc -88 66 -105 0 0 4.2 4.6 4.6 5.0 0.0 2.3 2.6 2.5 2.6 0.9 
DOPAH_33cc 132 -70 -98 0 0 4.4 4.8 4.7 5.5 0.0 2.6 2.8 2.6 3.2 0.6 
DOPAH_36cc 87 62 74 0 0 5.4 5.6 5.7 5.7 0.0 3.6 3.6 3.6 3.3 0.1 
DOPAH_35cc 85 61 -105 0 0 5.5 5.9 6.0 6.1 0.0 3.7 3.9 3.9 3.8 0.1 
  
     
   Σ 1.7    Σ 100 
DOPAH_11ct -73 -176 -78 -1 180 0.1 0.2 0.3 0.6 19.1 0.0 0.0 0.3 0.0 43.5 
DOPAH_12ct -73 -176 105 -1 -180 0.4 0.4 0.0 1.7 11.2 0.3 0.2 0.0 1.1 25.6 
DOPAH_14ct -51 -68 82 -2 -180 0.8 1.0 0.9 1.6 6.2 0.7 0.8 0.9 1.0 14.1 
DOPAH_13ct -51 -68 -98 1 180 1.0 1.2 1.2 1.7 3.9 0.9 1.0 1.2 1.1 9.0 
DOPAH_21ct 115 177 -77 -1 180 1.8 2.2 2.2 2.6 1.2 1.7 2.0 2.2 2.0 2.7 
DOPAH_22ct 109 179 107 0 -180 2.0 2.2 2.3 2.2 0.7 1.9 2.0 2.3 1.6 1.6 
DOPAH_16ct -87 66 73 -1 -180 2.3 2.6 2.7 2.9 0.5 2.2 2.4 2.7 2.3 1.1 
DOPAH_15ct -88 66 -105 1 -180 2.4 2.7 2.7 3.0 0.4 2.3 2.5 2.7 2.5 0.9 
DOPAH_34ct 133 -70 81 -3 180 2.4 2.7 2.7 3.3 0.4 2.3 2.5 2.7 2.7 0.9 
DOPAH_33ct 132 -70 -98 0 179 2.7 2.9 2.9 3.6 0.2 2.6 2.8 2.9 3.0 0.6 
DOPAH_36ct 87 63 74 0 -180 3.7 3.9 4.0 4.1 0.0 3.6 3.7 4.0 3.5 0.1 
DOPAH_35ct 86 62 -104 1 -180 3.8 4.0 4.1 4.1 0.0 3.7 3.8 4.1 3.6 0.1 
         Σ 54.8    Σ 100 
ΔE – energy difference from the minimum, ΔE0 – difference of the zero-point energy, ΔH – difference of the 





6.6.2 Spectral markers of different L-DOPA conformations 
The aim of this section is to find spectral characteristic of different L-DOPA 
conformers in the computed spectra, to compare them with the experimental spectra, 
and, based on this comparison, to estimate the most common conformers and their 
probable population. All weighted averages of the spectra presented in this section are 
based on the energies (ΔE) of the conformers. Firstly, in the Figure 6.16 we present 
VOA (Raman, ROA, IR, and VCD) spectra of all 36 conformers from the Error! 
Reference source not found. and their Boltzmann weighted average (BA). The 
comparison of the spectra of all conformers demonstrates the difference in the 
sensitivity of the four techniques to the changes in the conformation of L-DOPA. 
Unsurprisingly, the two chiral techniques (ROA and VCD) are substantially more 
sensitive to the conformational changes than their parental non-chiral techniques 
(Raman and IR), which is manifested in greater variability of the 36 spectra. The 
biggest variability in Raman and IR spectra is in the region of low spectral shift (0 – 
500 cm-1) and in the region of N–H3 vibrations (around 3500 cm
-1). However, the NH3 
bands in the experimental Raman spectra are not well differentiated due to the strong 
interaction with the solvent, lower region in the Raman spectra contains too many 
bands which often overlap and become undistinguishable. The IR spectra were 
measured only in the region from 900 to 1800 cm-1; therefore, comparison to both low-
wavenumber and N–H3 vibrations region remained inaccessible.   
In contrast, computed ROA and VCD spectra differ significantly depending on 
the conformation and the averaging has more significant effect than in the case of their 
parenting spectra. Chiral techniques are simply more sensitive to the conformational 
changes, which is why in the further conformer analysis we will focus mainly on them, 
and specifically on ROA because of the low quality of experimental VCD spectra, as 
discussed above in the section 6.5.1. 
In the Figure 6.17 three different averages are introduced: black line represent the 
BA of all 36 spectra where all three possible orientations of the phenyl OH groups (tc, 
cc, and ct) contribute equally to the final spectra, green line represents simple non-
weighted average of all 36 spectra, and finally, the orange line represents BA of all 36 
spectra where the ratio of the occurrence of the different orientations of OH groups is 
given by the results of the geometry optimisation (tc:cc:ct=43:2:55). The plain spectral 
average (green line) differs significantly from the two weighted averages and the 
differences do not correspond to the experimental, therefor spectra. The two weighted 
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spectra are almost identical; they differ only in the intensities, not in the positions of 
the bands. This validates the importance of the spectral weighing and confirms the 
assumption that certain conformers are preferred. Nevertheless, the computed ratio of 
the conformers with different OH orientations most probably does not correspond to 
the reality because our model uses only implicit solvent; hence, does not take into 
account the hydrogen bonds which are undoubtedly formed between the OH groups 
and H2O molecules of the solvent and stabilize the cc conformation. Thus, we assume 
that the contribution of the cc conformation is in fact much higher and comparable to 
the other two conformations. However, the fact that the two weighted spectra are 
almost identical means that the rate of occurrence of the three classes with different 
orientations of OH groups does not significantly influence the appearance of the 
spectra, as long as they are all present. This is further confirmed in Figure 6.18 where 
the comparison of BA spectra of the three groups of conformers with different OH 
orientation is given; the differences of their spectra are subtle, therefore, we decided 
to stick with the ratio tc:cc:ct=1:1:1.  
Next, we moved on to a more detailed examination of how the orientations of 
the other three torsion angles, α, β, and γ, influence the spectra. For every torsion angle 
we divided the conformers after the geometry optimisation (Error! Reference source 
not found.) into two or three groups based on the preferred orientations of that 
particular angle and made a Boltzmann weighted average of the relevant spectra. For 
angle α we divided the conformers into two groups: first with positive value of α (α+) 
and second with negative α (α-); for β there are three preferred orientations: trans 
(~180°) gauche+ (~+70°) and gauche- (~-70°); and for γ there are also two groups: 
with positive and with negative γ (γ+ and γ-). The results are shown in the Figure 6.19, 





Figure 6.16: Computed VOA spectra of all individual 36 conformers (black lines) and their 












Figure 6.17: Differently weighted averages of the computed spectra of all 36 conformers based 




Figure 6.18: Boltzmann-averaged spectra of the three groups of conformers with different 







In the Figure 6.19 a comparison of the spectra for two different orientations of α 
is shown. The most specific difference between them is the band corresponding to the 
vibration of the carboxyl group (~1800 cm-1). The orientation of the band has an 
opposite orientation in ROA spectra and it is shifted in other three spectra. The NH 
vibrations (~3500 cm-1) differ significantly but in the experimental Raman and IR 
spectra these bands are broadened and merged together, and they disappear completely 
in VOA and VCD due to the formation of hydrogen bonds between NH3 group and the 
water molecules of the solvent. This disables the comparison of NH3 bands with the 
computed spectra. Significant differences in the ROA spectra are observable also in 
the region ~ 1300 – 1600 cm-1. In the experimental spectra a -++--+ pattern is 
observable in this region to which clearly contribute both orientations of α (see Figure 
6.20). The estimate of the ratio of their occupation can be done based on the carboxyl 
valence vibration at 1720 cm-1 (around 1800 cm-1 in the computed spectra) which 
vanishes in the experimental ROA spectra thanks to the contribution from both 
conformers. Moreover, the width of the band in experimental Raman spectra also 
indicates that it is composed of two peaks which are however so close that they cannot 
be distinguished. Based on that, we can assume that despite the ratio of both 
conformers from geometry optimization is considerably unbalanced ((α+):(α-) = 6:94), 
the real ratio would be more even ((α+): (α-) ≈ 40:60). The α- orientation is preferred 
in the computational results due to the formation of hydrogen bond between the amine 
and carboxyl groups. In reality α+ conformation is stabilized by the hydrogen bonds 






Figure 6.19: Boltzmann weighted average VOA spectra of L-DOPA for two different 




Figure 6.20: Computed (top) and experimental (bottom) ROA spectra. Determination of the 
occurrence of two different orientation of the angle α.   
 
Figure 6.21 shows the comparison of spectra of three different orientations of the angle 
β (trans, t; gauche-, g-; gauche+, g+). Results of the geometry optimization showed us 
that their ratio is t:(g-):(g+) = 73:25:2. Change of β affects the spatial configuration of 
the alaninyl chain in an immediate proximity of the chiral carbon C2, so the value of β 
significantly influences spectra from the chiral techniques (ROA and VCD). From the 
comparison of the spectral characteristics (wavenumbers, intensites, and the sign of 
the bands) of the computed spectra with the experimental spectra, it is obvious that the 
trans conformation is dominant (60 – 70 %). The most convincing demonstration of 
that is the peak in ROA spectrum at 1375 cm-1 to which contributes only the trans 
conformation and which is clearly observable in the experimental spectrum at 1348 
cm-1 (see the Figure 6.22). The g- conformation is present in smaller but not negligible 
amount (20 – 30 %) which can be demonstrated on the negative band at 726 cm-1 (727 
cm-1 in the experiment), and finally, the g+ conformation is least represented (< 10 %) 
which we assume based on the fact that there are several bands of g+ and trans 
conformations with opposite sign in ROA, e.g. 800cm-1 and 1375 cm-1 or the couplet 
at 1476 a 1486 cm-1, but in the experimental spectra the signs of the corresponding 
peaks agree with those of the trans conformation and their intensity is not significantly 
lowered. Therefore, the experimental data are in a good agreement with the computed 





Figure 6.21: Boltzmann weighted average VOA spectra of L-DOPA for three different 




Figure 6.22: Computed (top) and experimental (bottom) ROA spectra. Determination of the 




Figure 6.23 shows the spectral comparison of two different orientations of γ (γ+ 
and γ-). Value of γ defines the orientation of the phenyl group. There is no chemical 
or spatial reason for neither of the orientations to be significantly preferred which is 
confirmed by the computed ratio of the conformers with different γ: (γ+):(γ–) = 57:43. 
ROA spectra appear to be very sensitive to the change of γ, VCD is less sensitive and 





Figure 6.23: Boltzmann weighted average VOA spectra of L-DOPA  for two different 







 Above, the probable percentage occurrences of the possible orientations of 
defined torsion angles were determined. Based on that we created a new modified 
weighting of conformers which satisfies those conditions: we adjusted the ratios of α+ 
and α- to 2:3 and ct:cc:ct to 1:1:1. Computed ratios for β (t:(g-):(g+) = 73:25:2) and δ 
(γ: (γ+):(γ–) = 57:43) were not changed as they are  in a good agreement with the 
experiment. Subsequently, BA VOA spectra with modified weighting were created. 
The comparison of this modified BA spectra (blue lines) to the original BA spectra 
(black lines) is shown in the picture Figure 6.24. The spectra differ marginally, 
however the slight differences in ROA spectra work in favour of the modified 
spectrum: the intensity of the couplet around 1470 cm–1 is higher in the modified 
spectrum, the difference in the intensities of the two peaks around 1350 cm-1 is bigger 
which corresponds better to the experiment, the negative band around at 775 cm-1 is 
the strongest one (without taking into account the strong band in the lowest part of the 
spectrum), and there are positive peaks at 569 and 720 cm-1 (see Figure 6.25). All these 
factors in which modified ROA spectrum differs from the non-modified are in a better 





Figure 6.24: Boltzmann average VOA spectra of L-DOPA weighted based on the computed 




Figure 6.25: Computed (top) and experimental (bottom) ROA spectra which correspond better 
to the BA spectra weighted by the modified computed ratios (blue line).  
 
6.6.3 Vibrational assignment of L-DOPA spectra  
As thoroughly discussed in the previous sections, L-DOPA in solution occurs in 
a dynamic equilibrium between many different conformations. Although all these 
conformations contribute to the measured signal (regardless of which of the VS 
method we use), their contribution depends on their relative occurrence. Therefore, we 
used the spectrum of the conformer with the highest relative occurrence, DOPAH_11tc 
(Table 6.5) for actual assignment of the vibrational modes. The vibrational assignment 
is shown in Table 6.6 along with the frequencies and intensities of corresponding 
experimental Raman, IR, ROA and VCD bands measured in 1M HCl. 
For the description of the vibrations we used the commonly used designation by Greek 
letters along with the designation of the tyrosine vibrations (Yx) introduced in 
(Profantová, 2013) and the Wilson’s nomenclature of benzene ring modes (νx; Wilson, 
1934), both are shown in the Figure 6.26. 
Due to the used approximations (namely the harmonic approximation) and a 
limited level of theory used for spectral simulation (B3PW91/6-311++G**/cpcm 
(water)), the simulated intensities are lightly upshifted in the lower spectral region and 
downshifted in the middle and higher regions; the turn occurs around 900 cm-1. The 
comparison of the experimental and simulated (modified BA of all conformers, see 




Figure 6.26: Tyrosine (a) and benzene (b) vibrational modes. Pictures are adopted from 

















1 39 -    -    whole structure twist 
2 51 -    -    whole structure twist 
3 64 
75 sh 
  -    whole structure bending 
4 79   96 s-   δ(CCC) aliphatic twist 
5 162 
166 m 
  -    δ(CCC) C1–C2–(C3Phe) 
6 175   -    δ(CCC) (Phe)–C3–C2 
7 184   169 s+   δ(ΝH3)  τ 
8 227 
222 w   207 m+   γ(CO–H) C3' C4' ip, δ(ΝCCC) Ν C2 C3 C1' 
246 sh   263 w-    
9 259 -    -    γ(CO–H) C3' C4' ip 
10 276 - 
 
  - 
 
  δ(C–CCΝ) C2–(COOH)(ΝH3)(CH2Phe), γ(CO–H) 





  δ(OCCO) C3' C4' 
12 311     δ(CCCΝ) C1' C3 C2 Ν, δ(OCCO) C3' C4' 
13 357 364 m   351/377 m-/vw-   δ(CCCΝ) C1' C3 C2 Ν 
14 396 392 sh   394 vw- 
  γ(CCCC) C1 C2 C3 C1', γ(CO–H) C3' C4' op, 
γ(CCC) ν16b 
15 413 424 m   423 m-   γ(CO–H) C3' C4' op 
16 455 457 w   468 m+   γ(CCC) ν16a 
17 463 479 vw   -    γ(CCC) ν16a 
18 498 
509 sh   
517 m+ 
  
δ(CCC) Phe νωz  
520 w     





  γ(CO–H) C1, δ(CCC) Y18  ν6b 
21 596     γ(CO–H) C1 
  623 sh   626 m-    
22 623 643 vw   642 sh   δ(CCΝ) C1 C2 Ν 
23 660 663 vw   665 w+   δ(CCCC) C1 C2 C3 C4,  γ(CCC) Y17a ν4 
24 716 
719 s 
  708 m+   γ(CCC) Y17a ν4, γ(OCO) 
25 725   727 m-   γ(CCC) Y17a ν4 
26 772 755 sh   -    δ(CCC) ν1 ring breathing δ(C–C–C) C3–C2–COO 
27 806 
773 sh   771 s-   
δ(CCC) ν1 ring breathing 785 sh   -    
798 s   799 s+   
28 820 820 sh   825 m+   γ(C–H) Y15 ν17b 
29 852 852 m   851 m-   γ(C–H) Y16 ν10a, δ (C–H2) ρ C3, ν(C–Ν) 
30 893 880 w   877 m-   γ(C–H) Y13 ν10b 
31 900 910 w   907 m+   ν(C–C) C1 C2, δ(C–H2) ρ C3 
32 947 -    -    γ(C–H) Y12 ν17a 
33 958 942 m 940 w 951 sh+   δ(C–C) C2 C3, δ (C–H2) ρ C3 
34 978 
969 m 970 w 967 s+   δ(C–H) Y11 ν18a 
990 sh 989 sh 993 w-    
35 1072 1054 sh 1055 sh 1057 w- 
  
ν(C–Ν) 
36 1090 1077 m 1077 sh 1080 m+   δ(Ν–H3) ω, δ(C–H2) τ C3, δ(C–H) C2 
37 1128 1124 m 1123 m 1115 w+   δ(C–H) Y10 ν15, δ(Ν–H3) ω, δ(C–H2) τ C3, δ(C–
H) C2,  δ(C–H) C2, δ(CO–H) C1 C3' 
38 1143 -  -  1140 w- 
  δ(Ν–H3) ω, δ(C–H2) τ C3, δ(C–H) C2, δ(CO–H) 
C1 C3' 
39 1170 1159 m 1158 sh 1156 w-   δ(C–H) Y10 ν15 
40 1187 1184 sh 1183 vw 1173 w+   δ(C–H) Y9a ν9a, δ(CO–H) C3' 
41 1189 -  -  1187 w+   δ(CO–H) C1, δ(Ν–H3) ω 
42 1209 1207 m 1208 sh 1205 w- 1209 w- δ(C–H) Y9 ν9a, δ(CO–H) C4' 
43 1253 1235 sh 1231 sh 1234 w+ 1231 m+ δ(C–H2) τ C3 , δ(C–H) C2 
44 1287 1256 sh 1257 sh -  1243 sh- δ(C–H2) τ C3 , δ(C–H) C2 
45 1295 1270 sh -  1268 m- 1250 s- δ(C–H) Y7, δ(C–H) C2 
46 1322 1295 s 1290 s 1298 m+ 
1276 m+ 
δ(C–H) Y8, δ(C–H2) Y8 τ C3 
47 1346 -  -  -  δ(C–H) Y6 ν3,  δ(C–H2) ω C3 
48 1361 1329 sh -  -  1300 s- δ(C–H2) ω C3, δ(C–H) C2, δ(C–H) Y6 ν3 
49 1380 -  -  -  1356 s- δ(C–H) C2, δ(C–H2) ω C3 
50 1416 1354 s 1342 sh 1348 s+  ν(C=C) Y5 ν14, δ(C–H2) C3 τ 
51 1447 1376 sh 1373 m 1378 w- 1377 w+ δ(C–H) C2, δ(C–O–H) C1 
52 1482 1403 sh 1410 sh -    δ(C–H2) σ C3 
53 1505 1446 m 1449 m 1436/1456 m-/m+ 1447 m+ ν(C=C) Y4 ν19b, δ(C–H2) σ C3 
54 1513 1471 sh 1472 sh -    δ(Ν-H3) ss 
55 1559 
1522 sh 1521 sh 
    - 
  
1532 w 1533 s   
95 
 
56 1635 -  -  -    δ(Ν-H3) as 
57 1654 1606 m 1607 s 
1604 
   ν(C=C) Y2 ν8b, δ(Ν-H3) as 
58 1664 -  -  w-   δ(Ν-H3) as 
59 1676 1623 sh 1627 sh    ν(C=C) Y1 ν8a 
60 1807 1734 m 1735 s -    ν(C=O) 
61 3083 2870 m   -    ν(C–H2) ss C3 , ν(C–H) C2 
62 3140 2941 s   2938  w+   ν(C–H2) as C3 , ν(C–H) C2 
63 3151 2977 sh   2970 w-   ν(C–H2) as C3 , ν(C–H) C2 
64 3199 3034 s   -    ν(C–H) C2' C5' C6' op 
65 3207 -    -    ν(C–H) C2' C5' C6' op 
66 3213 3081 s   -    ν(C–H) C2' C5' C6' ip 
67 3388 3214 w   -    ν(Ν–H3) ss 
68 3468 3245 sh   -    ν(Ν–H3) as 
69 3531 3275 sh   -    ν(Ν–H3) as 
70 3762 3464 sh   -    ν(O–H) C1 
71 3791 3517 sh   -    ν(O–H) C3' 
72 3846 3604 sh   -    ν(O–H) C4' 
Intensity: s – strong (35 – 100%), m – medium (10 – 35%), w – weak (3 – 10%), vw – very weak (1 – 3%), sh – shoulder, - – 
undetected, +/- marks ROA and VCD band sign 
γ – out-of-plane deformation, δ – in-plane deformation, ν – stretching, ρ – rocking, σ – scissoring, τ – twisting, ω – wagging 
ip – in phase, op – out of phase, ss – symmetric, as – antisymmetric 
Phe- phenyl ring 
* – B3PW91/6-311++G**/cpcm(water) DOPAH_11tc conformer 
 
 
The overall agreement between the experimental and calculated spectral profiles 
is very good; whether we take into account the positions of the bands, their relative 
intensities, and, in the case o ROA and VCD also their signs. Despite that, in all spectra 
there is a common region where this agreement is slightly worse, particularly in the 
intensities. It is the 1000 – 1250 cm-1 region, vibration modes 35 – 44 (according to 
the Table 6.6), where δ(C–OH) and δ(N–H3) vibrations are especially significant. 
However, this is not a surprise given the limitations of the implicit solvation model 
that was used. It is reasonable to assume that if we used the explicit solvation model 



















































































































































































6.7 VOA of deuterated L-DOPA analogues 
In this section we focus on the three deuterated derivatives of L-DOPA. We 
present the experimental Raman and ROA spectra of their 100 mg/ml solution in 1 M 
HCl and the simulated spectra of their cationic form. IR and VCD spectra of solid state 
samples are included in the Attachments as well as the liquid phase IR spectra. We 
were not able to obtained reliable VCD of liquid samples because only one enantiomer 
of each sample was available. In case of α,β-D2-L-DOPA we focus also on the 
assignment of its absolute configuration. Simulated spectra were obtained as modified 
BA (see subsection 0) of 36 individual deuterated conformers. The specectra were 
simulated at B3PW91/6-311++G**/cpcm(water) level of theory. 
6.7.1 Triple deuterated 2’,5’,6’-D3-L-DOPA (VI) 
Compared to other deuterated L-DOPA analogues, the isotopic exchange at 
phenyl hydrogen is rather distinct. The comparison of experimental and simulated 
spectra is shown in the Figure 6.28. The most pronounced changes when compared to 
the spectrum of non-deuterated L-DOPA (see Figure 6.11 or Figure 6.27) is the 
downshift of several bands corresponding to the phenyl vibrations in the fingerprint 
region and complete separation of the phenyl C–H stretching vibrations. All three 
modes associated with the stretches of phenyl hydrogens are shifted to 2200 – 2300 
cm-1. These vibrations have very weak ROA signal which cannot be identified in the 
experimental spectrum. This is not too surprising, considering that the phenyl group is 
planar and the nearest chiral centre is Cα. The recognizable ROA signal in C–H 
stretching region is formed by vibrations of Cβ and Cα hydrogens and it is well 
reproduced in simulated spectra. Quite surprisingly, we are able to distinguish the O–
H and even the N–H stretches in the experimental Raman spectrum. The overall 
correspondence of experimental and simulated spectra is very good and enables 
reliable band-to-band assignment of most of the spectral features, including the 
low-wavenumber (terahertz) region (down to ⁓75cm-1). In the Figure 6.28, the most 





Figure 6.28: Comparison of experimental (blue lines) and computed (black lines) Raman and 
ROA spectra of 2’,5’,6’-D3-L-DOPA 
 
6.7.2 Triple deuterated biologically active α,β,β-D3-L-DOPA (V) 
If we focus only to the deuterations at the “hard” positions (carbon atoms), the 
molecule V represents a complement to the molecule VI, which was the object of 
interest in the previous subchapter 6.7.1. (Deuteration at the “soft” positions – amine, 
hydroxyl, and carboxyl groups was discussed in the section 6.4.) In this case, the chiral 
carbons Cα and Cβ on the alaninyl chain of L-DOPA are deuterated. The comparison 
of the experimental and simulated spectra is shown in Figure 6.29.  
Similarly to the previous case, a clear separation of the C–H stretching modes is 
observable: phenyl CH vibrations with a negligible ROA signal remain unchanged and 
the rest of them (Cα–H and Cβ–H2) are shifted to 2100-2250 cm
-1 due to the isotopic 
exchange. Again, the experimental ROA signal of C–D stretches is quite well 
reproduced by the simulations. The changes in the rest of the spectrum are more subtle 
in comparison with the molecule VI, indicating that the vibrational modes of the 
phenyl group are more pronounced in both Raman scattering and ROA than the 
vibrational modes associated with Cα and Cβ atoms.  
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Also in this case, the overall agreement between the experimental and calculated 
spectra was at such good level that a reliable band-to-band assignment of most of the 
spectral features was enabled. In Figure 6.29, the most specific bands are labelled in 
the experimental as well as in the simulated spectra.  
 
 
Figure 6.29: Comparison of experimental (blue lines) and computed (black lines) Raman and 





6.7.3 Double deuterated biologically active α,β-D2-L-DOPA (IV) 
 
Partial deuteration at Cβ creates an additional chiral centrum in the molecule of 
α,β-D2-L-DOPA. While we know that non-deuterated L-DOPA occurs as a 
S-enantiomer, we do not know the chirality at the Cβ of the α,β-D2-L-DOPA sample. 
Therefore, the goal of this section is to determine the absolute configuration of 
α,β-D2-L-DOPA based on the comparison of computed spectra for S- and 
R-enantiomers and at Cβ their racemic mixture with the experimental spectra. The final 
experimental Raman and ROA spectra are shown in the Figure 6.30. IR spectra from 
1M HCl solution as well as solid-phase IR and VCD spectra can be found in the 
Attachments. 
In the Figure 6.31 we can see calculated VOA spectra of (S-α,S-β)-D2-L-DOPA, 
(S-α,R-β)-D2-L-DOPA and their racemic mixture. Figure 6.32 and Figure 6.33 show 
enlarged regions of ROA and Raman spectra, where the differences between both 
diastereomeric forms are most prominent. IR spectra appear insensitive to chirality at 
Cβ. VCD seems to be more sensitive at least in the region of δ(CH2) wagging and 
twisting vibrations, and δ(CH) bending. However, the changes are so fine that a highly 
resolved experimental VCD would be needed to distinguish between S- and 
R- chirality at Cβ. Unfortunately, the problem was getting a VCD spectrum of any 
quality, let alone high.  Raman spectra of both diastereomers differ in both fingerprint 
and C–H/C–D stretching region. Nevertheless, these changes are limited to differences 
in intensity of several bands (see Figure 6.32 and Figure 6.33) which are practically 
impossible to trace in the experimental spectrum.  
It is clear from what has been stated above that ROA is the only technique that is 
able to distinguish between different chirality on Cβ. The main differences can be 
found in three narrow spectral regions: (i) 900 – 1050 cm-1, where we observe a -++ 
pattern in the experimental ROA spectrum. This pattern corresponds exclusively to the 
S-enantiomer at Cβ. (The R-enantiomer shows a ++- pattern and the racemate has a 
+++ pattern.) (ii) 2100 – 2300 cm-1 (C–D stretching vibrations), where we observe a   
-+ pattern in the experiment. This is also most credibly expressed in the calculated 
spectrum of the S-enantiomer. (While both the R-enantiomer and the racemate show a 
+- pattern.) And finally, (iii): 2900 – 3050 cm-1 (C–H stretching region), where a          
+-- emerges in the experimental spectrum. The positive sign band corresponds to the 
symmetric C–H2 stretching vibrations, while both negative bands refer to the coupled 
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C–H and antisymmetric C–H2 stretches. Also in this case the calculated spectrum of 
S-enantiomer agrees best with the experiment. (The R-enantiomer shows a --- pattern 
and the racemate a +--- pattern.) The decisive factor in this case is the agreement of 
the sign of the symmetric C–H2 stretching vibrations.  
Thus, all three regions yield the same result. Namely, that the absolute 
configuration of sample IV, i.e., α,β-D2-L-DOPA, is (S-α,S-β)-D2-L-DOPA. The 
possibility of racemic mixture with respect to the configuration on Cβ is very unlikely. 
At most, it is a mixture of (S-α,S-β)- and (S-α,R-β)-enantiomers with a strongly 
predominant (S-α,S-β)-enantiomer.  
 
 




Figure 6.31: Theoretical VOA spectra of α,β-D2-L-DOPA in (S-α,S-β) and (S-α,R-β) 






Figure 6.32: Comparison of computed and experimental ROA and Raman spectra of 




Figure 6.33: Comparison of computed and experimental ROA and Raman spectra of 











The main goal of this thesis was an overall characterization of L-DOPA and its 
deuterated analogues by the methods of vibrational spectroscopy. This intention was 
fulfilled in an exhaustive manner. Evaluation of individual goals is summarized in 
following paragraphs:  
 
1. We elaborated a thorough review of Parkinson’s disease treatment mechanism by 
L-DOPA with an inclusion of the studies concerning the employment of 
L-DOPA’s deuterated derivatives. 
Review of previous research on L-DOPA’s vibrational analysis has revealed that 
such elaborate conformational analysis combined with vibrational assignment, as 
presented in this theses, has not been done before.  
2. The author (me) has learned to operate several vibrational spectrometers located 
at the Institute of Physics of Charles University, including Raman 
micro-spectrometer Alpha 300 RSA, Raman spectrometer SPEX, and VCD 
spectrometer ChiralIR-2XTM. I gained valuable experience in preparing of the 
samples for spectroscopic measurements, learned to set the appropriate 
measurement parameters and mastered the post-processing of raw experimental 
data. I also learned the basic skills necessary for quantum-chemical simulations, 
including searching of the conformational space, averaging the spectra based on 
thermodynamics potential values, and performing vibrational analysis.  
3. We successfully obtained the solid-phase Raman, IR, and even VCD spectra of 
both enantiomers of DOPA and also of its deuterated analogues. Comparing the 
spectra obtained from the liquid phase, we found that there is a high degree of 
similarity which suggests that L-DOPA samples in solid phase do not tend to form 
any supramolecular structures. Also the spectra of the same compound from 
different manufacturer showed a high degree of similarity.  
4. We have found that the liquid phase Raman, ROA, IR, and VCD spectra of DOPA 
samples are best obtained when DOPA is in the form of a cation, i.e. at pH<1, 
where sample concentrations of up to 100 mg/ml can be easily achieved. In the 
case of Raman scattering, we managed to obtain several spectra of neutral 
(zwitterionic) form of L-DOPA after a long effort. However, the differences in the 
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spectra between the cationic and zwitterionic forms were not very strong. 
Measurements in other solvents (DMSO, TFE, acetonitrile, and methanol) or at 
basic pH have not been proven appropriate.  
5. Thanks to measurements on a state-of-art ROA spectrometer, we were able to 
obtain a high quality ROA and Raman spectra of L-DOPA and its deuterated 
analogues in the entire range of fundamental molecular vibrations (75 – 4000 
cm-1). We also obtained IR and VCD spectra but the measurement of the latter has 
been proven to be very difficult because the DOPA samples show a relatively low 
absorbance (⁓0.2 at a concentration of 100 mg/ml and use of 15μm spacer). 
Measurement of a reliable VCD signal therefore required a use of both 
enantiomers.  
Nevertheless, we were able to describe in detail the spectral changes associated 
with deuteration at various carbon atoms as well as with the deuteration at easily 
exchangeable positions (amine, hydroxyl, and carboxyl groups). 
6. We performed a detailed scan of the conformational space of cationic form of 
L-DOPA molecule, found its most probable conformers, and determined their 
relative ratios. However, these results have only a limited informative value, as 
the simulations were performed merely with an implicit solvent model, therefore, 
did not quite correctly described the intermolecular hydrogen bonds. Therefore 
we adjusted the ratio of individual conformers based on the comparison of 
experimental and simulated spectra.  
7. After we included the dynamic aspect in the simulations (i.e. the balance between 
the individual conformations in which the molecule is found), we obtained a very 
good agreement of the experimental and simulated spectra of cationic form of 
L-DOPA and its variously deuterated analogues. Based on this, it was possible to 
perform a detailed vibrational analysis and an assignment of the individual bands. 
8. Finally, based on the comparison of calculated and measured ROA spectra, we 
were able to determine the absolute configuration of sample IV 
(α,β-D2-L-DOPA) which has an extra chiral centre at Cβ due to the deuteration. 
We have found that its configuration is (S- α,S-β). 
 
The latter result may also have practical application in the clinical research and in 
determination of the activity of new drugs for Parkinson’s disease based on deuterated 
L-DOPA analogues. In previously published studies, there is no mention of creation 
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of a new chiral centre at Cβ of L-DOPA, but the chirality of this atom could have a 
significant effect on the stability and the biological efficiency of the produced 
dopamine. Using ROA we are able to relatively easily distinguish between the 
different epimers of DOPA samples.  
In the future, we plan to focus primarily on further improving the calculations by 
including explicit solvation. We would also like to study other differently deuterated 
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A.1. IR spectra of L-DOPA deuterated analogues in a liquid state 
 
 
Figure A.1: IR spectrum of sample VI in a 100 mg/ml solution in 1M HCl. 
 
 
Figure A.2: IR spectrum of sample V in a 100 mg/ml solution in 1M HCl. 
 
 







A.2. IR spectra of L-DOPA deuterated analogues in a solid state 
 
In the figures presented below, * marks the remaining artefact of KBr and ** an 
artefact of unknown region.   
 









Figure A.6: IR spectrum of sample VI in a solid state. 
